
Pfizer Inc.
PFEHealthcare|Drug Manufacturers - General|US
$29.39
-0.06 (-0.20%)
DCF Value
$37.35
Graham Number
$15.77
Cash / Share
$2.50
Clinical Trials (941)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06862219 A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer | Metastatic Urothelial Carcinoma | P4 | Recruiting | 100 | Open-label | Enfortumab Vedotin |
| NCT07730450 A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age | COVID-19 Vaccines | P4 | Recruiting | 200 | RCT, Open-label | BNT162b2 Vaccine, Tdap Vaccine |
| NCT03395197 Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC | mCRPC | P3 | Active | 1,054 | RCT, Double-blind | Talazoparib with enzalutamide, Placebo with enzalutamide |
| NCT05253651 A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer | Colorectal Neoplasms | P3 | Recruiting | 400 | RCT, Open-label | tucatinib, trastuzumab, bevacizumab, cetuximab, oxaliplatin, leucovorin, levoleucovorin, fluorouracil |
| NCT04821622 Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC | Prostate Cancer | P3 | Active | 599 | RCT, Double-blind | talazoparib plus enzalutamide, Placebo plus enzalutamide |
| NCT06012435 A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer | Carcinoma, Non-Small-Cell Lung | P3 | Active | 762 | RCT, Open-label | sigvotatug vedotin, docetaxel |
| NCT02513394 PALbociclib CoLlaborative Adjuvant Study | Breast Cancer | P3 | Active | 5,796 | RCT, Open-label | Palbociclib, Standard Adjuvant Endocrine Therapy |
| NCT07566156 Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309) | Urothelial Cancer, Urinary Bladder Neoplasms | P3 | Recruiting | 390 | RCT, Open-label | Enfortumab vedotin, Cisplatin, Fluorouracil, Mitomycin C, Gemcitabine, Pembrolizumab |
| NCT05909397 Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer | Breast Cancer | P3 | Active | 59 | RCT, Open-label | Vepdegestrant (ARV-471/PF-07850327), Letrozole |
| NCT05911295 Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 | Urothelial Carcinoma | P3 | Active | 412 | RCT, Open-label | disitamab vedotin, pembrolizumab, gemcitabine, cisplatin, carboplatin |
| NCT02319837 Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) | Hormone Sensitive Prostate Cancer, Prostate Cancer | P3 | Active | 1,068 | RCT | Enzalutamide, Placebo (No longer applicable in Open Label study period), Leuprolide Open Label |
| NCT06650579 REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial | Recurrent Prostate Carcinoma, Stage III Prostate Cancer AJCC v8 | P3 | Recruiting | 72 | RCT, Double-blind | Abiraterone Acetate, Bicalutamide, Leuprolide, Prednisone, Relugolix |
| NCT03975647 A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer | HER2-positive Breast Cancer | P3 | Active | 466 | RCT, Double-blind | tucatinib, placebo, T-DM1 |
| NCT05654623 A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer | Advanced Breast Cancer | P3 | Active | 624 | RCT, Open-label | ARV-471, Fulvestrant |
| NCT05132582 A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer | HER2 Positive Breast Cancer | P3 | Active | 654 | RCT, Double-blind | Tucatinib, Trastuzumab, Pertuzumab, Combination product: Trastuzumab + Pertuzumab, Placebo |
| NCT06807281 A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema | Atopic Dermatitis | P3 | Recruiting | 450 | Open-label | Abrocitinib |
| NCT07846683 A Study to Assess the Efficacy and Safety of Subcutaneous Induction Therapy With Afimkibart in Participants With Moderately to Severely Active Ulcerative Colitis | Moderately to Severely Active Ulcerative Colitis | P3 | Recruiting | 350 | RCT, Double-blind | Afimkibart, Placebo |
| NCT05020236 A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments | Multiple Myeloma | P3 | Recruiting | 893 | RCT, Open-label | Elranatamab, Daratumumab, Pomalidomide, Dexamethasone |
| NCT03820830 Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer | Breast Cancer Recurrent | P3 | Active | 405 | RCT, Open-label | Palbociclib 125mg, Standard endocrine therapy |
| NCT07222800 Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer | Intestinal Neoplasms, Gastrointestinal Neoplasms | P3 | Recruiting | 800 | RCT, Double-blind | PF-08634404, Bevacizumab, Chemotherapy |
| NCT03485209 Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors | Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung | P2 | Active | 350 | Open-label | tisotumab vedotin, pembrolizumab, carboplatin, cisplatin |
| NCT04579380 Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations | Uterine Neoplasms, Uterine Cervical Neoplasms | P2 | Active | 217 | Open-label | tucatinib, trastuzumab, fulvestrant |
| NCT03260023 Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers | HPV-Related Carcinoma, HPV-Related Cervical Carcinoma | P1P2 | Active | 143 | RCT, Open-label | TG4001, Avelumab |
| NCT03297606 Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) | Lymphoma, Non-Hodgkin, Multiple Myeloma | P2 | Recruiting | 720 | Open-label | Olaparib, Dasatinib, Nivolumab plus Ipilimumab, Axitinib, Bosutinib, Crizotinib, Palbociclib, Sunitinib, Temsirolimus, Erlotinib, Trastuzumab plus Pertuzumab, Vemurafenib plus Cobimetinib, Vismodegib, Tucatinib |
| NCT05868226 PRE-ISPY Phase I/II Oncology Platform Program | HER2-positive Breast Cancer, Metastatic Cancer | P1P2 | Recruiting | 280 | Open-label | ALX148, Fam-Trastuzumab Deruxtecan-Nxki, Zanidatamab, Tucatinib, TTX-MC138 |
| NCT02960022 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study | Prostate Cancer | P2 | Active | 900 | Open-label | enzalutamide, abiraterone acetate, prednisone, Leuprolide acetate |
| NCT06206837 A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer. | Breast Cancer | P1P2 | Active | 71 | Open-label | vepdegestrant, PF-07220060 |
| NCT03911973 Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers | TNBC - Triple-Negative Breast Cancer | P1P2 | Active | 37 | Open-label | Gedatolisib, Talazoparib |
| NCT06157892 A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors | Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma | P2 | Active | 54 | RCT, Open-label | disitamab vedotin, tucatinib |
| NCT06330805 Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer | Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8 | P2 | Recruiting | 70 | RCT, Open-label | Leuprolide, Relugolix |
| NCT03809000 A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery | Prostate Cancer | P2 | Active | 188 | RCT, Open-label | Enzalutamide, Bicalutamide, GnRH analog |
| NCT07421700 Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer | Urothelial Cancer, Advanced/Metastatic Urothelial Cancer | P1P2 | Recruiting | 132 | Open-label | PF-08634404, Enfortumab Vedotin |
| NCT05548127 TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A) | Breast Cancer | P1P2 | Active | 37 | Open-label | ARV-471, Abemaciclib |
| NCT04879329 A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 | Urothelial Carcinoma | P2 | Recruiting | 372 | RCT, Open-label | disitamab vedotin, pembrolizumab |
| NCT02693535 TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer | Lymphoma, Non-Hodgkin, Multiple Myeloma | P2 | Recruiting | 4,200 | Open-label | Sunitinib (CLOSED TO ENROLLMENT), Trastuzumab and Pertuzumab (CLOSED TO ENROLLMENT), Vemurafenib and Cobimetinib (CLOSED TO ENROLLMENT), Olaparib (CLOSED TO ENROLLMENT), Nivolumab and Ipilimumab (CLOSED TO ENROLLMENT), Abemaciclib (CLOSED TO ENROLLMENT), Talazoparib (CLOSED TO ENROLLMENT), Atezolizumab and Talazoparib (CLOSED TO ENROLLMENT), Tucatinib plus Trastuzumab Subcutaneous (SC) (CLOSED TO ENROLLMENT), Futibatinib, Dabrafenib plus Trametinib, Fam-Trastuzumab Deruxtecan-Nxki (TDxD) |
| NCT05892068 A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain | Metastatic Breast Cancer | P2 | Active | 9 | Open-label | Tucatinib |
| NCT04430738 Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers | Colorectal Carcinoma, Gastric Adenocarcinoma | P2 | Active | 40 | Open-label | tucatinib, trastuzumab, oxaliplatin, leucovorin, fluorouracil, capecitabine, pembrolizumab |
| NCT05170334 Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma | Metastatic Uveal Melanoma | P2 | Active | 7 | Open-label | Binimetinib, Belinostat |
| NCT05765500 RecoverPC: Relugolix vs GnRH Agonist in Quality of Life | Prostate Cancer, Prostatic Neoplasms | P2 | Recruiting | 110 | RCT, Single-blind | Relugolix, Leuprolide |
| NCT04486352 A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer | Endometrial Cancer | P1P2 | Recruiting | 148 | Open-label | Atezolizumab - 28 Day Cycle, Bevacizumab, Ipatasertib, Talazoparib, Trastuzumab emtansine, Tiragolumab, Atezolizumab - 21 Day Cycle, Inavolisib, Letrozole, Giredestrant, Abemaciclib |
| NCT04901702 Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma | Recurrent Solid Tumor, Recurrent Ewing Sarcoma | P1P2 | Recruiting | 90 | RCT, Open-label | Onivyde, Talazoparib, Temozolomide |
| NCT01396408 A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours | Advanced Rare Tumours | P2 | Active | 137 | Open-label | Sunitinib, Temsirolimus |
| NCT06106308 Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation | Metastatic Colorectal Cancer, CRC | P2 | Active | 110 | RCT, Open-label | Onvansertib, FOLFIRI, Bevacizumab, FOLFOX |
| NCT03971409 Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer | Stage III Breast Cancer, Stage IIIA Breast Cancer | P2 | Active | 145 | RCT, Open-label | Anti-OX40 Antibody PF-04518600, Avelumab, Binimetinib, Utomilumab, Liposomal Doxorubicin, Sacituzumab Govitecan |
| NCT07575932 A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity | Overweight, Obesity | P2 | Active | 940 | RCT, Double-blind | PF-08653945, PF-08653944, Placebo |
| NCT06183489 Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma | Smoldering Multiple Myeloma | P2 | Active | 50 | Open-label | Elranatamab |
| NCT04039230 Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. | Breast Cancer | P1P2 | Active | 75 | Open-label | Talazoparib, Sacituzumab Govitecan |
| NCT06966453 A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer | Breast Cancer, Breast Neoplasms | P1P2 | Active | 74 | Open-label | Disitamab vedotin |
| NCT05071937 ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer | Ovarian Cancer, Peritoneal Cancer | P2 | Recruiting | 33 | Open-label | ZEN003694, Talazoparib |
| NCT04227847 A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies | Myelodysplastic Syndrome, Acute Myeloid Leukemia | P1 | Active | 170 | Open-label | SEA-CD70, azacitidine, Venetoclax |
| NCT04389632 A Study of Sigvotatug Vedotin in Advanced Solid Tumors | Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck | P1 | Recruiting | 1,006 | Open-label | sigvotatug vedotin, pembrolizumab, cisplatin, carboplatin |
| NCT04846478 Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC | Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer | P1 | Active | 35 | Open-label | Talazoparib, Tazemetostat |
| NCT06130995 Relugolix + Enzalutamide Study in High-Risk Prostate Cancer | Androgen Deprivation Therapy, Locally Advanced Prostate Cancer | P1 | Recruiting | 46 | Open-label | Relugolix and Enzalutamide |
| NCT03454035 Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors | Tumor, Solid, Pancreatic Cancer | P1 | Recruiting | 45 | Open-label | Ulixertinib, Palbociclib |
| NCT05266105 A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients | Breast Cancer | P1 | Active | 60 | Open-label | Palazestrant, Palbociclib |
| NCT05508906 Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer | Metastatic Breast Cancer, ER-positive Breast Cancer | P1 | Active | 190 | Open-label | Palazestrant, Ribociclib, Alpelisib, Everolimus, Atirmociclib |
| NCT06131840 A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors | Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung | P1 | Recruiting | 914 | Open-label | PF-08046050, bevacizumab, 5-Fluorouracil (5-FU), Oxaliplatin, Leucovorin (LV) |
| NCT05208762 A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors | Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck | P1 | Recruiting | 714 | Open-label | PF-08046054, pembrolizumab |
| NCT07231991 A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function | Healthy Participants | P1 | Recruiting | 24 | Open-label | vepdegestrant |
| NCT07519135 A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function | Healthy | P1 | Recruiting | 26 | Open-label | PF-08653944 |
| NCT07677358 A Study to Learn How the Study Medicine Called Atirmociclib is Handled by the Body in People With Normal Liver Function and Different Levels of Liver Disease | Hepatic Impairment, Healthy, Hepatic Insufficiency | P1 | Recruiting | 28 | Open-label | Atirmociclib |
| NCT07206225 A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer | Non-muscle Invasive Bladder Cancer | P1 | Recruiting | 294 | Open-label | PF-08052667, Sasanlimab, BCG, PF-02921367 |
| NCT07754266 Headache Ear Auditory Dizziness Sinus (HEADS) Registry | Headache Disorders, Dizziness | Recruiting | 10,000 | — | — | |
| NCT05198245 Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy | Migraine | Active | 1 | — | Rimegepant, Various | |
| NCT07332312 A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California | Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | N/A | Recruiting | 71 | Open-label | — |
| NCT05479721 LITMUS Imaging Study | NAFLD, NASH | Active | 450 | — | — | |
| NCT01731353 FungiScope - A Global Emerging Fungal Infection Registry | Invasive Fungal Disease | Recruiting | 1,000 | — | — | |
| NCT03870620 Metastatic Breast Cancer in Austria | Breast Cancer, Breast Carcinoma | Recruiting | 5,000 | — | — | |
| NCT03275311 Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008 | Metastatic Breast Cancer | Recruiting | 42,000 | — | — | |
| NCT05885009 Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102) | Metastatic Prostate Cancer | Recruiting | 240 | — | — | |
| NCT04998877 Physical Activity, Cardiac and Skeletal Muscle Energetics in Healthy Subjects and HFpEF Patients | Heart Failure With Preserved Ejection Fraction | Active | 60 | — | — | |
| NCT04876781 Korean Post-marketing Surveillance for Xeljanz XR | Active Moderate to Severe Rheumatoid Arthritis, Active Ankylosing Spondylitis | Recruiting | 200 | — | Tofacitinib XR | |
| NCT03870919 Locoregional Treatment and Palbociclib in de Novo, Treatment Naive, Stage IV ER+, HER2- Breast Cancer Patients | Breast Cancer Stage IV, Radiotherapy | N/A | Active | 200 | Open-label | Palbociclib |
| NCT06647654 Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy | Respiratory Syncytial Virus, Respiratory Tract Diseases | Active | 1 | — | ABRYSVO | |
| NCT05189639 A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia | Acute Myeloid Leukemia | Recruiting | 165 | — | — | |
| NCT05733104 A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea | Complicated Intra-abdominal Infection, Complicated Urinary Tract Infection | Recruiting | 600 | — | — | |
| NCT00414115 National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children | Adverse Drug Reaction (ADR) | Recruiting | 7,000 | — | — | |
| NCT06495164 A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer | Breast Cancer, Malignant Neoplasm of Breast | Active | 1 | — | Palbociclib, Aromatase inhibitor, Ribociclib, Abemaciclib | |
| NCT06864585 A Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Japan | Infectious Diseases | Active | 59 | — | Avibactam sodium/Ceftazidime hydrate | |
| NCT00474175 Benzocaine Gel Toothache Dose-Response Study | Toothache | P4 | Completed | 577 | RCT, Double-blind | Placebo gel, benzocaine, benzocaine |
| NCT01190007 Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients | Hypertension, Hypercholesterolemia | P4 | Completed | 159 | Open-label | Caduet |
| NCT00297973 Cardiovascular Risk Assessment in Patients Treated With Caduet | Hypertension | P4 | Completed | 1,442 | RCT, Open-label | — |
| NCT00442325 Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets | Coronary Arteriosclerosis, Diabetes Mellitus, Type 2 | P4 | Completed | 595 | Open-label | Atorvastatin (Lipitor) |
| NCT02060487 Effects of Oral Sildenafil on Mortality in Adults With PAH | Pulmonary Arterial Hypertension | P4 | Terminated | 385 | RCT, Double-blind | sildenafil citrate, sildenafil citrate, sildenafil citrate |
| NCT00174395 A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine | Migraine | P4 | Completed | 220 | RCT, Open-label | eletriptan |
| NCT00644800 A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis | Schizophrenia, Mania | P4 | Completed | 89 | Open-label | Ziprasidone |
| NCT00381095 A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer | Bone Neoplasms, Pain, Intractable | P4 | Terminated | 152 | RCT, Double-blind | Pregabalin, Placebo |
| NCT00139776 Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use" | Osteoarthritis, Knee, Osteoarthritis, Hip | P4 | Completed | 875 | RCT, Double-blind | Celecoxib, Celecoxib |
| NCT00323297 Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension | Pulmonary Arterial Hypertension | P4 | Completed | 105 | RCT, Double-blind | Bosentan, Bosentan, Sildenafil Citrate |
| NCT00645320 A Study of Ziprasidone for the Treatment of Psychosis in Patients Who Had Already Had Benefits From Ziprasidone Treatment in a Previous Study | Pyschotic Disorders | P4 | Completed | 75 | Open-label | Ziprasidone |
| NCT00728988 Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome | Acute Coronary Syndrome | P4 | Completed | 499 | RCT, Open-label | Atorvastatin, Atorvastatin |
| NCT00646841 Effects of Doxazosin Gastrointestinal Therapeutic System on Ambulatory Blood Pressure and Cardiovascular Risk Factors in Uncontrolled Hypertensive Patients | Hypertension | P4 | Completed | 89 | Open-label | Doxazosin gastrointestinal therapeutic system (GITS) |
| NCT00640627 Efficacy and Safety of Celecoxib Versus Placebo in the Treatment of Patients With Osteoarthritis of the Knee Who Were Unresponsive to Naproxen and Ibuprofen | Osteoarthritis, Knee | P4 | Completed | 380 | RCT, Double-blind | Celecoxib, Placebo |
| NCT00143195 Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina | Myocardial Ischemia | P4 | Completed | 200 | RCT, Open-label | Amlodipine, iso- 5 - mononitrate |
| NCT00143377 Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB | Urinary Incontinence | P4 | Completed | 600 | RCT, Double-blind | tolterodine SR, overactive bladder |
| NCT00147654 Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction | Urinary Incontinence | P4 | Completed | 830 | RCT, Double-blind | Tolterodine ER 4 mg QD, Tamsulosin 0.4 mg QD |
| NCT00159679 Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy | Diabetic Neuropathy, Painful | P4 | Completed | 167 | RCT, Double-blind | Pregabalin |
| NCT00137397 A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder | Urinary Incontinence | P4 | Completed | 80 | RCT, Double-blind | Tolterodine ER, Placebo |
| NCT00359151 Celebrex Total Knee Arthroplasty Study | Osteoarthritis, Pain | P4 | Terminated | 22 | RCT, Double-blind | Celecoxib, Placebo |
| NCT00245596 Evaluation of the Index of Sexual Life Questionnaire | Impotence | P4 | Completed | 120 | Open-label | sildenafil |
| NCT00994461 Study Of Celecoxib In Healthy Subjects | Healthy Volunteers | P4 | Completed | 190 | RCT, Double-blind | Celecoxib, Loxoprofen, Placebo |
| NCT00634985 Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory Drugs | Migraine | P4 | Completed | 120 | Open-label | eletriptan |
| NCT01176968 Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction | Myocardial Infarction | P4 | Completed | 1,012 | RCT, Double-blind | Eplerenone, Placebo |
| NCT00855738 A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice | Focal Epilepsy | P4 | Completed | 111 | Open-label | Gabapentin, Lamotrigine, Levetiracetam, Pregabalin, Oxcarbacepine, Tiagabine, Topiramate, Zonisamide |
| NCT00407537 Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors | Hypertension, Hypercholesterolemia | P4 | Completed | 1,531 | RCT, Open-label | Amlodipine besylate/atorvastatin calcium single pill combination |
| NCT00807846 A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects | Arthritis, Juvenile Rheumatoid | P4 | Completed | 201 | RCT, Double-blind | Celecoxib, Naproxen |
| NCT00082589 The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure | Heart Failure, Congestive | P4 | Completed | 250 | RCT, Double-blind | Eplerenone |
| NCT00645268 A Multicenter, Double-blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 Diabetes | Erectile Dysfunction, Diabetes Mellitus, Type 2 | P4 | Completed | 300 | RCT, Double-blind | sildenafil, placebo, sildenafil |
| NCT00230789 Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication. | Urinary Incontinence | P4 | Completed | 417 | Open-label | Tolterodine ER 4 mg QD |
| NCT04741204 Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer | Breast Cancer Stage, Insulin Resistance | P4 | Withdrawn | — | Open-label | Metformin Extended Release Oral Tablet |
| NCT00708370 A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients. | Dyslipidemia | P4 | Completed | 297 | RCT, Open-label | — |
| NCT01977651 A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide | Metastatic Castration-resistant Prostate Cancer (mCRPC) | P4 | Completed | 424 | Open-label | Enzalutamide |
| NCT00301262 Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied | Impotence | P4 | Completed | 183 | RCT, Double-blind | Viagra (Sildenafil citrate) |
| NCT00430716 To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension. | Pulmonary Arterial Hypertension | P4 | Terminated | 130 | RCT, Double-blind | Sildenafil citrate, Sildenafil citrate, Sildenafil citrate, Sildenafil citrate |
| NCT01298466 Primary Care Identification Of Patients With Chronic Neuropathic Low Back Pain Study | Low Back Pain, Neuralgia | P4 | Withdrawn | — | Open-label | Pregabalin |
| NCT00159757 12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients | Schizophrenia | P4 | Terminated | 150 | Open-label | ziprazidone |
| NCT00644956 A Randomized, Open-Label, Crossover, Multicenter, Single Dose Comparator Study Evaluating Onset Of Penile Rigidity In Men With Erectile Dysfunction Who Are Treated With Sildenafil And Tadalafil | Erectile Dysfunction | P4 | Completed | 56 | RCT, Open-label | tadalafil, sildenafil |
| NCT00644631 A Multicenter, Randomized, Parallel Group, Double-Blind, Placebo Controlled, Flexible Dose Escalation Study To Evaluate Sexual And Relationship Satisfaction In The Female Partner Of Men With Erectile Dysfunction Treated With Sildenafil Citrate | Erectile Dysfunction | P4 | Completed | 300 | RCT, Double-blind | sildenafil, placebo |
| NCT01995513 Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients | Prostate Cancer | P4 | Completed | 509 | RCT, Double-blind | Enzalutamide, Abiraterone, Placebo for Enzalutamide, Prednisone |
| NCT00249730 Titration Study to Evaluate Efficacy and Satisfaction of Viagra in Men With Erectile Function. | Impotence | P4 | Completed | 510 | RCT, Double-blind | Sildenafil |
| NCT00654017 A Study Evaluating the Efficacy and Safety of Sildenafil in Patients With Erectile Dysfunction Receiving Hemodialysis | Erectile Disfunction, Hemodialysis | P4 | Completed | 100 | RCT, Double-blind | placebo, sildenafil |
| NCT00477659 Neural Correlates In Mild Alzheimer's Disease | Alzheimer's Disease | P4 | Completed | 14 | Open-label | Donepezil hydrochloride |
| NCT00245258 Study to Evaluate Viagra's Ability to Provide a Better Sexual Experience Through Quality Erections and Satisfaction | Impotence | P4 | Completed | 312 | RCT, Double-blind | Sildenafil Citrate |
| NCT00894790 Celecoxib Efficacy And Safety Versus Diclofenac In Acute Pain Due To Cervical Sprain Related To A Traffic Accident | Pain | P4 | Terminated | 8 | RCT, Open-label | Celecoxib, oral Diclofenac |
| NCT00648323 Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement | Prostate | P4 | Completed | 80 | Open-label | Doxazosin mysylate GITS |
| NCT00631696 Evaluation Of Sperm Production With Healthy Male Volunteers Receiving Lyrica Or Placebo | Healthy | P4 | Completed | 222 | RCT, Double-blind | Pregabalin, Placebo |
| NCT00159718 Double Blind Atorvastatin Amlodipine Study | Angina | P4 | Completed | 360 | RCT, Double-blind | amlodipine, atorvastatin |
| NCT00163150 Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke | Cerebrovascular Accident, Hypercholesterolemia | P4 | Completed | 128 | RCT, Double-blind | Atorvastatin |
| NCT00647101 A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma | Glaucoma, Open-Angle, Ocular Hypertension | P4 | Completed | 600 | Open-label | Latanoprost |
| NCT00629681 A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia | Painful Diabetic Neuropathy and Post Herpetic Neuralgia | P4 | Completed | 217 | Open-label | Pregabalin |
| NCT00282932 Detrol LA In Men With Overactive Bladder. | Overactive Bladder (OAB) | P4 | Completed | 600 | RCT, Double-blind | Detrol LA |
| NCT00159900 Quality of Erection Study | Erectile Dysfunction | P4 | Completed | 300 | RCT, Double-blind | Sildenafil Citrate |
| NCT00159692 Amlodipine Diabetic Hypertension Efficacy Response Trial | Hypertension | P4 | Completed | 739 | RCT, Double-blind | Amlodipine |
| NCT01020526 Pregabalin In Adolescent Patients With Fibromyalgia | Fibromyalgia | P4 | Completed | 63 | Open-label | pregabalin |
| NCT00159666 Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia | Post-Herpetic Neuralgia | P4 | Completed | 255 | RCT, Double-blind | pregabalin |
| NCT00143260 Study Of Men With Mild To Moderate Erectile Dysfunction To Evaluate The Efficacy Of Viagra 8 Hours Post-Dose | Impotence | P4 | Completed | 250 | RCT, Double-blind | Viagra (Sildenafil Citrate) 100 mg |
| NCT00351611 Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo | Epilepsies, Partial | P4 | Completed | 187 | RCT, Double-blind | Lyrica (pregabalin), placebo |
| NCT01455428 Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN) | Postherpetic Neuralgia ( PHN ) | P4 | Completed | 223 | RCT, Double-blind | Lyrica (pregabalin), Placebo |
| NCT00174330 Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia | Hypertension, Hyperlipidemia | P4 | Completed | 330 | RCT, Open-label | atorvastatin, amlodipine |
| NCT01322867 A Bioequivalence Study Of A New Alprazolam Dropped Formulation Versus Alprazolam Tablets | Healthy | P4 | Completed | 30 | RCT, Open-label | alprazolam tablet, alprazolam oral solution |
| NCT00304772 Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients | Candidiasis, Sepsis | P4 | Withdrawn | — | RCT, Single-blind | Fluconazole, Micafungin |
| NCT02918968 Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer | Prostate Cancer | P4 | Completed | 206 | RCT, Open-label | Enzalutamide, Flutamide |
| NCT00640549 Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus | Hyperlipidemia, Diabetes Mellitus, Type 2 | P4 | Terminated | 41 | RCT, Double-blind | Atorvastatin, Placebo |
| NCT00634348 A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients | Schizophrenia | P4 | Completed | 256 | RCT, Double-blind | Aripiprazole, Ziprasidone |
| NCT00346216 Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen | Arthritis, Rheumatoid | P4 | Completed | 24,081 | RCT, Double-blind | celecoxib, Ibuprofen, Naproxen |
| NCT00156078 A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN) | Diabetic Neuropathy, Painful | P4 | Completed | 450 | RCT, Double-blind | pregabalin |
| NCT00239109 Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia. | Schizophrenia | P4 | Completed | 112 | RCT, Double-blind | Ziprasidone, Olanzapine |
| NCT00635531 A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder | Panic Disorder | P4 | Terminated | 16 | RCT, Double-blind | alprazolam XR |
| NCT00677352 A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder | Panic Disorder | P4 | Completed | 321 | RCT, Double-blind | sertraline, Paroxetine |
| NCT00624780 Safety and Efficacy Evaluation Of Pregabalin (Lyrica) With Patients With Generalized Anxiety Disorder | Generalized Anxiety Disorder | P4 | Completed | 615 | RCT, Double-blind | Pregabalin, Lorazepam, Pregabalin, Placebo |
| NCT00406315 Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone | Schizophrenia, Schizoaffective Disorder | P4 | Completed | 255 | Open-label | ziprasidone |
| NCT00917644 Bioequivalence Study Comparing A New 80 Mg Atorvastatin Tablet To A 80 Mg Atorvastatin Commercial Tablet | Hypercholesterolemia | P4 | Completed | 76 | RCT, Open-label | Atorvastatin |
| NCT00446797 Open Label Comparative Study On Celecoxib Efficacy And Safety Vs Non-Selective NSAID In Acute Pain Due To Ankle Sprain | Ankle Sprain | P4 | Completed | 278 | RCT, Open-label | Non-selective NSAIDS, Celecoxib |
| NCT00644982 A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression | Depressive Disorder, Major | P4 | Completed | 163 | RCT, Double-blind | sertraline, venlafaxine XR |
| NCT00647543 Atorvastatin Study For The Treatment Of High Cholesterol In Patients From Thailand | Dyslipidemias | P4 | Completed | 242 | Open-label | Atorvastatin, Atorvastatin, Atorvastatin |
| NCT01257542 Acute Cough Study In Children | Common Cold, Infections, Upper Respiratory Tract | P4 | Terminated | 140 | RCT, Double-blind | Dextromethorphan, Placebo |
| NCT01642407 Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension | Pulmonary Arterial Hypertension, Hypertension, Pulmonary | P4 | Completed | 6 | Open-label | Sildenafil |
| NCT01727791 A Study Of Pregabalin (Lyrica) Drug Levels In Urine, Plasma And Breast Milk Of Healthy Lactating Women | Healthy Lactating Women | P4 | Completed | 10 | Open-label | pregabalin (Lyrica) |
| NCT00645151 A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol | Dyslipidemias | P4 | Completed | 512 | Open-label | Atorvastatin, Atorvastatin, Atorvastatin |
| NCT00571064 The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility | Mild to Severe Alzheimer's Disease | P4 | Completed | 97 | Open-label | Donepezil HCl |
| NCT00411437 Effects Of Detrol LA On Memory And Cognition In Elderly Population | Memory, Cognition | P4 | Completed | 220 | RCT, Double-blind | Tolterodine ER, Oxybutynin ER |
| NCT00640432 Safety And Efficacy Of Celecoxib Versus Sodium Diclofenac In The Treatment Of Acute Low Back Pain | Low Back Pain | P4 | Completed | 244 | RCT, Double-blind | Diclofenac, Celecoxib |
| NCT00468650 A Multicenter, Open Label, To Evaluate The Efficacy And Satisfaction Of Patrex® In Men With Erectile Dysfunction. | Erectile Dysfunction | P4 | Completed | 117 | Open-label | sildenafil citrate |
| NCT01302938 Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder | Overactive Bladder | P4 | Terminated | 18 | RCT, Double-blind | Tolterodine ER, Placebo |
| NCT00644748 A Study on the Efficacy and Safety of Gabapentin in the Treatment of Patients With Painful Diabetic Neuropathy | Diabetic Neuropathies | P4 | Completed | 95 | Open-label | gabapentin |
| NCT00373685 GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS) | Osteoarthritis | P4 | Completed | 8,067 | RCT, Open-label | Celecoxib, Any commercially available NSAID with the indication for osteoarthritis |
| NCT00140049 A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma | Glaucoma, Open Angle, Ocular Hypertension | P4 | Completed | 238 | RCT, Single-blind | Xalacom, Cosopt |
| NCT00151463 QEQ Treatment Responsiveness Evaluation Study | Impotence | P4 | Completed | 100 | Open-label | sildenafil citrate |
| NCT00230568 EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD) | Alzheimer's Disease | P4 | Completed | 100 | Open-label | Aricept |
| NCT00143481 Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women | Urinary Incontinence | P4 | Completed | 400 | RCT, Double-blind | Tolterodine ER 4mg QD |
| NCT00174304 Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia. | Hypertension, Hyperlipidemia | P4 | Completed | 1,120 | RCT, Open-label | Amlodipine/atorvastatin single pill |
| NCT00540293 Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study | Dyslipidemias | P4 | Completed | 425 | Open-label | Atorvastatin |
| NCT00407797 Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial | Partial Seizures | P4 | Terminated | 136 | Open-label | Pregabalin |
| NCT00141427 Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial. | Seizures | P4 | Completed | 540 | Open-label | Pregabalin |
| NCT00380874 Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer | Chemotherapy-Induced Peripheral Neuropathy | P4 | Terminated | 64 | RCT, Double-blind | Pregabalin, Placebo |
| NCT00638807 Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and Ibuprofen | Osteoarthritis, Knee | P4 | Completed | 388 | RCT, Double-blind | Celecoxib |
| NCT00654082 A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction | Spinal Cord Injury, Erectile Dysfunction | P4 | Completed | 88 | RCT, Double-blind | sildenafil, placebo |
| NCT02116582 A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer | Metastatic Castration-Resistant Prostate Cancer | P4 | Completed | 215 | Open-label | Enzalutamide |
| NCT00632385 Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy | Migraine | P4 | Completed | 127 | Open-label | Eletriptan |
| NCT00143221 Effectiveness and Safety of Viagra in Men With ED and LUTS Due to Benign Prostatic Hyperplasia (BPH) | Impotence | P4 | Completed | 350 | RCT, Double-blind | Viagra, Placebo |
| NCT00640809 Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole | Bowel Diseases, Inflammatory | P4 | Completed | 408 | RCT, Double-blind | Celecoxib, Ibuprofen plus Omeprazole |
| NCT00648596 A Study to Evaluate Self-esteem and Relationships in Males With Erectile Dysfuntion | Erectile Dysfunction | P4 | Completed | 780 | RCT, Double-blind | sildenafil, placebo |
| NCT00666796 A Study to Assess the Pharmacodynamic Interaction Between Gabapentin and Ethanol in Healthy Subjects | Insomnia | P4 | Completed | 20 | RCT, Double-blind | Placebo ethanol, Ethanol, Placebo, Gabapentin, Ethanol, Placebo, Gabapentin, Placebo ethanol |
| NCT00412113 A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk | Dyslipidemia, Hypertension | P4 | Completed | 245 | RCT, Double-blind | Amlodipine besylate, Amlodipine besylate/atorvastatin calcium single pill combination, Amlodipine besylate, Amlodipine besylate/atorvastatin calcium single pill combination |
| NCT00159809 Efficacy Study Measuring The Impact Of Treatment With Viagra On The Depressive Symptoms Of Men With Erectile Dysfunction | Impotence, Depression | P4 | Completed | 140 | RCT, Double-blind | Viagra (Sildenafil citrate) |
| NCT00634790 A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks | Panic Disorder | P4 | Terminated | 49 | Open-label | alprazolam XR |
| NCT00219570 Dalacin-T Gel Post Approval Study | Acne Vulgaris | P4 | Completed | 134 | RCT, Single-blind | clindamycin, nadifloxacin |
| NCT00163202 Comparative Atorvastatin Pleiotropic Effects | Coronary Arteriosclerosis, Hypercholesterolemia | P4 | Completed | 330 | RCT, Double-blind | Atorvastatin |
| NCT00137072 Mild To Moderate Erectile Dysfunction Study | Impotence | P4 | Completed | 355 | RCT, Double-blind | Viagra (Sildenafil Citrate) 100 mg |
| NCT00484718 Measuring Gait And Self-Reported Pain In Patients With Osteoarthritis Of The Knee Using Placebo/Oxycodone/Celecoxib. | Osteoarthritis | P4 | Terminated | 6 | RCT, Double-blind | celecoxib, Oxycodone, placebo |
| NCT00889720 A Pilot Study Of Smoking Cessation Treatment Including Varenicline In Patients Scheduled For Planned Surgery | Smoking Cessation | P4 | Completed | 16 | Open-label | Varenicline |
| NCT00153972 Dopamine Turnover Rate as Surrogate Parameter for Diagnosis of Early Parkinson's Disease | Parkinson's Disease | P4 | Completed | 39 | RCT, Single-blind | Cabergoline, Levodopa |
| NCT00548262 This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis | Candidemia, Invasive Candidiasis | P4 | Completed | 54 | Open-label | Anidulafungin, Voriconazole |
| NCT05329259 A Study to Describe the Safety of a Vaccine (Called 13vPnC) in Healthy People 18 to 49 Years of Age in India | Pneumococcal Disease | P4 | Completed | 200 | Open-label | 13-valent pneumococcal conjugate vaccine |
| NCT01068873 Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study) | HIV Infections | P4 | Terminated | 1 | Open-label | lopinavir/ritonavir plus maraviroc |
| NCT01061697 Pregabalin and Radicular Pain Study (PARPS) | Cervical Spondylosis, Cervical Spondylotic Myelopathy | P4 | Completed | 50 | Open-label | Pregabalin |
| NCT05518123 Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications | Migraine | P4 | Completed | 962 | RCT, Double-blind | Rimegepant, Placebo |
| NCT00344019 Effects of Atorvastatin on Myonecrosis | Coronary Disease | P4 | Terminated | 97 | RCT, Double-blind | Placebo Oral Tablet, Atorvastatin 80mg |
| NCT02307825 Azithromycin for Patients With Chronic Rhinosinusitis Failing Medical and Surgical Therapy | Chronic Rhinosinusitis, High-risk Patient | P4 | Completed | 129 | RCT, Double-blind | Azithromycin, Placebo |
| NCT00307944 Study of Pantoprazole for Sleepiness Associated With Acid Reflux and Sleep Apnea | Acid Reflux Disease, Obstructive Sleep Apnea | P4 | Completed | 68 | RCT, Double-blind | Pantoprazole |
| NCT02415400 A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart | Acute Coronary Syndromes | P4 | Completed | 4,614 | RCT, Open-label | Apixaban, vitamin K antagonist, Acetylsalicylic acid |
| NCT00138060 Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants | Metastatic Colorectal Cancer | P4 | Completed | 71 | Open-label | irinotecan, 5 fluorouracil |
| NCT00496197 Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis | Candidiasis | P4 | Completed | 282 | Open-label | Eraxis (anidulafungin), Diflucan (fluconazole), Vfend (voriconazole) |
| NCT01350596 A Bioequivalence Study Of Ibuprofen 50mg/ml (laboratórios Pfizer Ltda) In The Oral Suspension Form. | Healthy | P4 | Completed | 24 | RCT, Open-label | Alivium®, Ibuprofen |
| NCT00195507 Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis | Psoriasis | P4 | Completed | 720 | RCT, Open-label | Etanercept |
| NCT03937609 TITRATE (inducTIon for acuTe ulceRATivE Colitis) | Colitis, Ulcerative | P4 | Terminated | 50 | RCT, Open-label | Infliximab |
| NCT00276107 Study Evaluating Prevenar Vaccine in Healthy Infants | Pneumococcal Infections | P4 | Completed | 200 | Open-label | Prevenar |
| NCT00194090 Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced Walk | Knee Osteoarthritis | P4 | Completed | 40 | RCT, Double-blind | celecoxib |
| NCT01721408 A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection | Intra-abdominal Infection | P4 | Completed | 470 | RCT, Double-blind | Tigecycline, Imipenem/cilastatin |
| NCT00354445 A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD | Age-Related Macular Degeneration (AMD) | P4 | Unknown | 1,000 | Open-label | pegaptanib sodium (Macugen) |
| NCT00936065 Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis | Moderate to Severe Psoriasis | P4 | Completed | 60 | RCT, Open-label | Etanercept, Etanercept + Acitretin, Acitretin |
| NCT01056289 Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD) | Major Depressive Disorder | P4 | Completed | 480 | RCT, Double-blind | Desvenlafaxine Succinate Sustained-Release Formulation 50 mg, Desvenlafaxine Succinate Sustained-Release Formulation 25 mg, Placebo |
| NCT00649090 A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer | Breast Neoplasms | P4 | Completed | 1,549 | Open-label | exemestane |
| NCT05080218 COVID-19 VaccinE Response in Rheumatology Patients | Rheumatoid Arthritis, Psoriatic Arthritis | P4 | Completed | 841 | RCT, Open-label | Upadacitinib, Abatacept, Secukinumab, Tofacitinib, TNF Inhibitor, Canakinumab Injection, Baricitinib, Ixekizumab |
| NCT02819921 Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen | Hot Flashes, Breast Neoplasms | P4 | Terminated | 59 | RCT, Double-blind | Desvenlafaxine succinate 100mg, Desvenlafaxine succinate 50mg, Placebo |
| NCT00139724 Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet | Urinary Incontinence | P3 | Completed | 260 | RCT, Double-blind | tolterodine extended release capsule |
| NCT00954590 A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease | Moderate to Severe Alzheimer | P3 | Terminated | 89 | RCT, Double-blind | Dimebon (latrepirdine), Placebo |
| NCT01113541 One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome | Bipolar Disorder | P3 | Terminated | 13 | Open-label | Ziprasidone HCL (oral) |
| NCT00596466 Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures | Epilepsy | P3 | Completed | 75 | Open-label | pregabalin |
| NCT00905437 Study To Investigate The Effectiveness Of Pregabalin For Management Of Patients Undergoing Total Hip Replacement | Pain, Perioperative | P3 | Terminated | 72 | RCT, Double-blind | Placebo, Pregabalin |
| NCT00800267 A Study of Glaucoma or Ocular Hypertension in Patients Within the United States | Ocular Hypertension, Glaucoma | P3 | Completed | 418 | RCT, Double-blind | latanoprost 0.005%, fixed combination latanoprost-timolol, timolol 0.5% |
| NCT00716859 A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma. | Glaucoma | P3 | Completed | 139 | RCT, Double-blind | Timolol, latanoprost |
| NCT00383019 A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH). | Glaucoma, Ocular Hypertension | P3 | Completed | 300 | RCT, Double-blind | Xalatan, Xalacom |
| NCT01270828 Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia | Post Herpetic Neuralgia | P3 | Completed | 806 | RCT, Double-blind | Pregabalin, placebo |
| NCT00151450 Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder | Anxiety | P3 | Completed | 390 | RCT, Double-blind | Pregabalin, Venlafaxine XR |
| NCT00143130 Pregabalin In Partial Seizures Extension Study | Seizures | P3 | Completed | 227 | Open-label | Pregabalin |
| NCT00159887 Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension | Pulmonary Hypertension | P3 | Completed | 260 | Open-label | Sildenafil citrate |
| NCT01152216 An Extension of the CONCERT Protocol (DIM18) | Alzheimer's Disease | P3 | Terminated | 672 | Open-label | Dimebon |
| NCT02288247 A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone | Metastatic Castration Resistant Prostate Cancer | P3 | Completed | 688 | RCT, Double-blind | Enzalutamide, Docetaxel, Prednisolone, Placebo |
| NCT00974311 Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy | Castration-Resistant Prostate Cancer | P3 | Completed | 1,199 | RCT, Double-blind | Enzalutamide, Placebo |
| NCT00806026 Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients | Idiopathic Restless Legs Syndrome | P3 | Completed | 731 | RCT, Double-blind | placebo and pregabalin, pramipexol, pramipexol, Pregabalin, pramipexol, pramipexol |
| NCT00150306 A Ten-Week Study Evaluating The Effectiveness And Safety Of Zoloft In Children And Adolescents With A Diagnosis Of PTSD | Stress Disorders, Post-Traumatic | P3 | Terminated | 160 | RCT, Double-blind | Zoloft (Sertraline) |
| NCT00666770 A Polysomnographic Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance | Transient Insomnia | P3 | Completed | 309 | RCT, Double-blind | Gabapentin, Gabapentin, Placebo |
| NCT00415623 A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient | Hypertension | P3 | Completed | 305 | RCT, Double-blind | Amlodipine, Amlodipine |
| NCT01202227 An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain | Spinal Cord Diseases, Spinal Cord Injuries | P3 | Completed | 104 | Open-label | pregabalin |
| NCT00143156 Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy | Diabetic Neuropathies | P3 | Completed | 450 | RCT, Double-blind | pregabalin |
| NCT00407745 A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury | Neuralgia, Spinal Cord Injuries | P3 | Completed | 220 | RCT, Double-blind | placebo, pregabalin |
| NCT00219596 Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension | Glaucoma, Open Angle, Ocular Hypertension | P3 | Completed | 240 | RCT, Open-label | Xalacom, unfixed Latanoprost and Timolol |
| NCT00159861 The Efficacy and Safety of Sildenafil Citrate Used in Combination With Intravenous Epoprostenol in PAH | Pulmonary Hypertension | P3 | Completed | 267 | RCT, Double-blind | Sildenafil citrate |
| NCT00330785 Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia | Hypertension, Dyslipidemia | P3 | Completed | 1,250 | Open-label | Amlodipine/Atorvastatin |
| NCT00551135 Surgical Pain After Inguinal Hernia Repair (SPAIHR) | Pain, Postoperative, Hernia, Inguinal | P3 | Completed | 425 | RCT, Double-blind | Pregabalin, placebo, Pregabalin, Pregabalin |
| NCT01864746 A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery | Breast Cancer, Hormonreceptor Positive | P3 | Completed | 1,250 | RCT, Double-blind | Palbociclib PD-0332991, Placebo |
| NCT00762463 Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis | Ankylosing Spondylitis | P3 | Completed | 240 | RCT, Double-blind | Celecoxib, Diclofenac SR |
| NCT00219544 Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain. | Neuropathic Pain | P3 | Completed | 158 | RCT, Double-blind | Pregabalin (Lyrica), Pregabalin (Lyrica), Pregabalin (Lyrica), Placebo |
| NCT01986270 Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo | Migraine With or Without Aura | P3 | Completed | 1,141 | RCT, Double-blind | Placebo, Eletriptan 40 mg, Eletriptan 80 mg, Sumatriptan 25 mg, Sumatriptan 50 mg |
| NCT00141271 A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression | Bipolar Disorder | P3 | Completed | 536 | RCT, Double-blind | Geodon (Ziprasidone), Geodon (Ziprasidone), Placebo |
| NCT00232141 Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy | HIV Infections, Peripheral Neuropathy | P3 | Completed | 302 | RCT, Double-blind | pregabalin, Placebo |
| NCT01057693 Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy | Diabetic Neuropathy, Painful | P3 | Completed | 633 | RCT, Double-blind | pregabalin (Lyrica), Placebo |
| NCT01701362 Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain | Neuropathic Pain | P3 | Completed | 542 | RCT, Double-blind | pregabalin, placebo |
| NCT00401362 A a Single Dose Efficacy Study in Inducing Laxation in Advance Illness Patients | Advanced Illness Patients With Opioid Induced Constipation | P3 | Completed | 154 | RCT, Double-blind | SC Methylnaltrexone, SC Placebo, SC Methylnaltrexone |
| NCT00139737 Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia | Schizophrenia | P3 | Completed | 344 | Open-label | Ziprasidone |
| NCT00163046 A 28-Day Polysomnographic Study of Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance | Transient Insomnia | P3 | Completed | 256 | RCT, Double-blind | Gabapentin, Placebo |
| NCT00312494 3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects | Bipolar Disorder | P3 | Completed | 680 | RCT, Double-blind | Placebo, Ziprasidone, Ziprasidone |
| NCT01117220 Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196) | Bipolar Disorder | P3 | Withdrawn | — | RCT, Double-blind | Placebo, Ziprasidone Oral Capsules |
| NCT00830128 A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin In Patients With Fibromyalgia | Fibromyalgia | P3 | Completed | 106 | Open-label | pregabalin (Lyrica) |
| NCT00150280 Compare Celecoxib and Ibuprofen Sr In The Management Of Acute Pain Post Orthopedic Or Gynecological Surgery | Pain, Postoperative | P3 | Completed | 132 | RCT, Double-blind | celecoxib and ibuprofen SR |
| NCT00827606 Atorvastatin Three Year Pediatric Study | Familial Hypercholesterolemia | P3 | Completed | 272 | Open-label | atorvastatin |
| NCT03768726 Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder | Bipolar Disorder | P3 | Terminated | 23 | Open-label | Ziprasidone, Placebo |
| NCT00645372 A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients | Schizophrenia | P3 | Completed | 242 | RCT, Double-blind | Risperidone, Ziprasidone |
| NCT00468845 Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo For Treatment Of Post-Surgical Pain From Hysterectomy | Pain, Postoperative | P3 | Completed | 501 | RCT, Double-blind | pregabalin (Lyrica), pregabalin (Lyrica), matched placebo |
| NCT00829374 Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil | Alzheimer's Disease | P3 | Completed | 1,003 | RCT, Double-blind | Dimebon, Dimebon, Placebo comparator |
| NCT00751062 A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia | Open Angle Glaucoma, Ocular Hypertension | P3 | Completed | 267 | RCT, Double-blind | timolol, PhXA41 |
| NCT00280059 Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy | Epilepsy, Partial | P3 | Completed | 660 | RCT, Double-blind | Pregabalin, Lamotrigine |
| NCT00644605 A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertension | Hypertension, Pulmonary | P3 | Completed | 275 | RCT, Double-blind | sildenafil, sildenafil, placebo, sildenafil |
| NCT00354081 WENBIT - Western Norway B Vitamin Intervention Trial | Coronary Artery Disease, Myocardial Infarction | P3 | Completed | 3,096 | RCT, Double-blind | folic acid, vitamin B12 (cyanocobalamin), vitamin B6 (pyridoxine), folic acid, vitamin B12 (cyanocobalamin), vitamin B6 (pyridoxine), placebo |
| NCT01485887 Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD) | Major Depressive Disorder | P3 | Completed | 50 | Open-label | Venlafaxine ER |
| NCT00282464 A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression. | Bipolar Disorder | P3 | Completed | 392 | RCT, Double-blind | Placebo, Geodon (Ziprasidone) |
| NCT00666939 A Study of Single-Dose Gabapentin in Subjects With Transient Insomnia Induced by a Sleep Phase Advance | Transient Insomnia | P3 | Completed | 773 | RCT, Double-blind | Gabapentin, Gabapentin, Placebo |
| NCT00401375 Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI) | Post-Operative Ileus (POI) | P3 | Completed | 524 | RCT, Double-blind | Methylnaltrexone, Placebo |
| NCT00645515 A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic Schizophrenia | Schizophrenia | P3 | Terminated | 240 | RCT, Double-blind | Ziprasidone, Risperidone |
| NCT00723606 A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With Agitation | Schizophrenia | P3 | Completed | 376 | RCT, Open-label | Intramuscular ziprasidone mesylate, Intramuscular haloperidol |
| NCT00448916 Open-Label Extension Study Of Safety And Tolerability Of Pregabalin In Pediatric Patients With Partial-Onset Seizures | Epilepsies, Partial | P3 | Completed | 54 | Open-label | Pregabalin |
| NCT01271933 Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients | Fibromyalgia | P3 | Completed | 441 | RCT, Double-blind | pregabalin, placebo |
| NCT01978496 Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine | Migraine With or Without Aura | P3 | Completed | 1,334 | RCT, Double-blind | Placebo, Eletriptan 20 mg, Eletriptan 40 mg, Eletriptan 80 mg |
| NCT00147615 The Long-term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 Years | Hypertension | P3 | Completed | 140 | Open-label | Eplerenone |
| NCT01049217 Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy | Neuropathy | P3 | Terminated | 377 | RCT, Double-blind | pregabalin, placebo |
| NCT00553280 A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy | Diabetic Neuropathy, Painful | P3 | Completed | 123 | Open-label | pregabalin |
| NCT00301223 A Study to Assess the Efficacy, Safety and Tolerability of Pregabalin in Patients With Symptoms of Neuropathic Pain | Neuropathic Pain | P3 | Completed | 309 | RCT, Double-blind | Pregabalin |
| NCT00141258 Pregabalin Epilepsy Add-On Trial | Partial Seizures | P3 | Completed | 178 | RCT, Double-blind | pregabalin |
| NCT01145417 Pregabalin Trial In HIV Neuropathic Pain | HIV-1 Infection, Neuropathic Pain | P3 | Terminated | 217 | Open-label | pregabalin (Lyrica) |
| NCT00151528 An Open-Label Trial of Pregabalin in Patients With Fibromyalgia | Fibromyalgia | P3 | Completed | 428 | Open-label | Pregabalin |
| NCT01474772 Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN) | Diabetic Peripheral Neuropathy | P3 | Completed | 217 | RCT, Double-blind | Pregabalin |
| NCT00372528 An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures | Epilepsy | P3 | Terminated | 21 | Open-label | pregabalin (LYRICA) |
| NCT01085266 An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease | Huntington Disease | P3 | Terminated | 362 | Open-label | Dimebon (latrepirdine) |
| NCT00163241 Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression | Osteoarthritis | P3 | Terminated | 666 | RCT, Double-blind | celecoxib |
| NCT01262677 Once-A-Day Pregabalin For Partial Seizures | Partial Seizures, Epilepsies, Partial | P3 | Completed | 325 | RCT, Double-blind | pregabalin, pregabalin, pregabalin, pregabalin, pregabalin, pregabalin, placebo |
| NCT00553475 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy | Diabetic Neuropathy, Painful | P3 | Completed | 314 | RCT, Double-blind | placebo, pregabalin, pregabalin |
| NCT00649844 A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs | Schizophrenia | P3 | Completed | 147 | RCT, Double-blind | Clozapine, Ziprasidone |
| NCT02072824 A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures. | Partial Onset Seizures | P3 | Completed | 175 | RCT, Double-blind | Pregabalin Dose Level 1, Pregabalin Dose Level 2, Placebo |
| NCT00265382 Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia | Schizophrenia | P3 | Terminated | 221 | Open-label | Ziprasidone oral capsules |
| NCT00136994 IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study) | Schizophrenia | P3 | Completed | 160 | Open-label | Ziprasidone |
| NCT06218069 Immuno-pet IMaging ResPonses AdministeRed Immune CheckpoiNt InhibiTor | NSCLC | P2P3 | Not Yet Recruiting | 20 | Open-label | Sasanlimab, [89Zr]Zr-crefmirlimab berdoxam |
| NCT01859481 Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study | Migraine Without Aura, Migraine With Aura | P3 | Completed | 971 | RCT, Double-blind | Placebo, Eletriptan HBr 40 mg, Eletriptan HBr 80 mg |
| NCT04424511 Effects of Mass Drug Administration of Azithromycin on Mortality and Other Outcomes Among 1-11 Month Old Infants in Mali | Mortality | P3 | Completed | 149,201 | RCT, Double-blind | Placebo, Azithromycin |
| NCT00856622 A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients | Ocular Hypertension, Glaucoma | P3 | Completed | 436 | RCT, Double-blind | i. Fixed combination of latanoprost 0.005% and timolol 0.5%, timolol 0.5% ophthalmic solution, latanoprost 0.005% ophthalmic solution |
| NCT00530946 A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin | Hypertension, Hypercholesterolemia | P3 | Completed | 165 | RCT, Open-label | Amlodipine 2.5mg/Atorvastatin 5mg, Amlodipine 2.5mg/Atorvastatin 10mg, Amlodipine 5mg/Atorvastatin 5mg, Amlodipine 5mg/Atorvastatin 10mg |
| NCT00159770 Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients | Schizophrenia, Schizoaffective Disorder | P3 | Completed | 290 | RCT, Open-label | ziprasidone versus olanzapine , risperidone or quetiapine |
| NCT00265330 Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed) | Bipolar Disorder | P3 | Completed | 169 | Open-label | Ziprasidone oral capsules |
| NCT01332149 Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy | Diabetic Neuropathy, Painful | P3 | Completed | 626 | RCT, Double-blind | Pregabalin, Placebo matched with pregabalin |
| NCT00976716 An Open-Label Study Of Celecoxib In Patients With Posttraumatic Pain | Pain | P3 | Completed | 80 | Open-label | Celecoxib |
| NCT01945775 A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) | Breast Neoplasms, BRCA 1 Gene Mutation | P3 | Completed | 431 | RCT, Open-label | talazoparib, Physician's-Choice |
| NCT00667108 A Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance | Transient Insomnia | P3 | Completed | 784 | RCT, Double-blind | Gabapentin, Gabapentin, Placebo |
| NCT01432236 A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression | Fibromyalgia | P3 | Completed | 197 | RCT, Double-blind | Pregabalin, placebo |
| NCT00151489 Safety and Efficacy Study of Pregabalin in Fibromyalgia | Fibromyalgia | P3 | Completed | 1,020 | RCT, Double-blind | pregabalin, placebo |
| NCT00912288 A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease | Alzheimer Disease | P3 | Terminated | 86 | RCT, Double-blind | Dimebon 20 mg po TID, Placebo po TID |
| NCT02075047 Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder | Bipolar Disorder | P3 | Terminated | 171 | RCT, Double-blind | placebo oral capsules, ziprasidone oral capsules |
| NCT00174447 Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031 | Schizophrenia | P3 | Completed | 43 | Open-label | Ziprasidone |
| NCT00230763 Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure | Glaucoma, Primary Open Angle (POAG), Ocular Hypertension | P3 | Completed | 396 | Open-label | LATANOPROST 0.005% / TIMOLOL 0.5% FIXED COMBINATION |
| NCT01212991 A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer | Prostate Cancer | P3 | Completed | 1,717 | RCT, Double-blind | Enzalutamide, Placebo |
| NCT00232180 A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines | Heart Failure | P3 | Completed | 2,743 | Open-label | Eplerenone |
| NCT03447132 Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant | Breast Neoplasm Female | P3 | Completed | 354 | RCT, Double-blind | Fulvestrant 500mg, Palbociclib 125mg, Goserelin 3.6 MG, Placebos |
| NCT00920946 A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease | Huntington Disease | P3 | Completed | 403 | RCT, Double-blind | Dimebon |
| NCT01389596 A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years | Epilepsy, Partial Seizures | P3 | Completed | 295 | RCT, Double-blind | Pregabalin add-on therapy, Pregabalin add-on therapy, Pregabalin add-on therapy |
| NCT01115855 Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure | Heart Failure | P3 | Completed | 221 | RCT, Double-blind | Eplerenone, Placebo |
| NCT01989936 Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan | Migraine With or Without Aura | P3 | Completed | 446 | RCT, Double-blind | Placebo, Eletriptan 40 mg, Eletriptan 80 mg |
| NCT00549549 Celebrex In Acute Gouty Arthritis Study | Arthritis, Gouty | P3 | Completed | 402 | RCT, Double-blind | Indomethacin, Celecoxib, Celecoxib, Celecoxib |
| NCT02929576 Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer | Breast Cancer | P3 | Withdrawn | — | RCT, Double-blind | Enzalutamide, Placebo, Paclitaxel |
| NCT04501978 ACTIV-3: Therapeutics for Inpatients With COVID-19 | Covid19 | P3 | Completed | 2,753 | RCT, Double-blind | LY3819253, Placebo, Remdesivir, VIR-7831, BRII-196/BRII-198, AZD7442, MP0420, PF-07304814 |
| NCT00751049 A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom | Ocular Hypertension, Open Angle Glaucoma | P3 | Completed | 294 | RCT, Double-blind | timolol, PhXA41 |
| NCT01061372 12-Week Efficacy And Safety Of Pregabalin In Treating Restless Legs Syndrome (RLS) Subjects | Restless Legs Syndrome | P3 | Withdrawn | — | RCT, Double-blind | Placebo, pregabalin, pregabalin |
| NCT00159653 A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma | Glaucoma, Open-Angle, Ocular Hypertension | P3 | Completed | 500 | RCT, Double-blind | Xalacom, Xalatan, Timolol |
| NCT00754052 Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17 | Down Syndrome, Cognitive Dysfunction | P3 | Terminated | 8 | RCT, Double-blind | Aricept (donepezil hydrochloride), Aricept (donepezil hydrochloride), Placebo |
| NCT01066546 An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease | Alzheimer's Disease | P3 | Terminated | 5 | Open-label | Dimebon tablet for oral administration |
| NCT01248416 Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature | Idiopathic Short Stature | P3 | Completed | 76 | RCT, Open-label | Aromatase Inhibitor, Growth Hormone, Aromatase Inhibitor and Growth Hormone |
| NCT00838110 A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease | Alzheimer's Disease | P3 | Completed | 742 | RCT, Double-blind | Dimebon, Placebo, Dimebon, Placebo |
| NCT00159913 A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension. | Pulmonary Arterial Hypertension, Children | P3 | Completed | 235 | RCT, Double-blind | Sildenafil citrate, Sildenafil citrate, Placebo, Sildenafil citrate |
| NCT00804141 Study Evaluating Long-Term Safety of MOA-728 in Participants With Opioid-Induced Constipation | Constipation | P3 | Completed | 1,040 | Open-label | N-methylnaltrexone bromide (MOA-728) |
| NCT00141154 Comparison Of Celecoxib 200 Mg Bid, Loxoprofen Sodium 60 Mg Tid And Placebo In Low Back Pain In Japan | Low Back Pain | P3 | Completed | 1,234 | RCT, Double-blind | Celecoxib, Placebo, Loxoprofen |
| NCT00346034 This Study is An Open-Label Trial Of Pregabalin In Patients With Fibromyalgia | Fibromyalgia | P3 | Completed | 357 | Open-label | Pregabalin |
| NCT00368745 Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use. | Generalized Anxiety Disorder | P3 | Completed | 108 | RCT, Double-blind | Pregabalin, Placebo |
| NCT00442546 Efficacy And Safety Of Pregabalin For Pain Following Total Knee Replacement | Osteoarthritis, Postoperative Pain | P3 | Completed | 307 | RCT, Double-blind | pregabalin, pregabalin, Placebo |
| NCT00939783 An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease | Alzheimer's Disease | P3 | Terminated | 649 | Open-label | Dimebon |
| NCT00631943 A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain | Neuralgia | P3 | Completed | 112 | Open-label | Pregabalin (Lyrica) |
| NCT00159874 A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children | Pulmonary Arterial Hypertension | P3 | Completed | 234 | RCT, Open-label | Sildenafil citrate, Sildenafil citrate, Sildenafil citrate |
| NCT00883740 Effects Of Pregabalin (Lyrica) On Sleep Maintenance In Subjects With Fibromyalgia | Fibromyalgia, Sleep Disorders | P3 | Completed | 119 | RCT, Double-blind | Pregabalin, Placebo |
| NCT00343655 Evaluation of Atorvastatin Treatment on Carotid Plaque. | Cardiovascular Diseases | P3 | Terminated | 160 | RCT, Double-blind | Atorvastatin |
| NCT01986088 Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study | Migraine With or Without Aura | P3 | Completed | 1,008 | RCT, Double-blind | Placebo, Eletriptan 40 mg, Eletriptan 80 mg, Sumatriptan 50 mg, Sumatriptan 100 mg |
| NCT00143234 Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol Levels | Hypertension, Hyperlipidemia | P3 | Completed | 1,825 | Open-label | Amlodipine/atorvastatin single pill |
| NCT00394901 A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia | Neuralgia, Postherpetic | P3 | Completed | 372 | RCT, Double-blind | Placebo, Pregabalin, Pregabalin, Pregabalin |
| NCT00007657 Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation | Myocardial Ischemia | P3 | Completed | 3,260 | RCT, Open-label | — |
| NCT02504294 A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis | Chronic Kidney Disease (CKD) | P3 | Completed | 432 | RCT, Open-label | Epoetin Hospira Arm, IV Iron |
| NCT00630851 A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes | Alzheimer Disease | P3 | Completed | 249 | RCT, Double-blind | Donepezil (Aricept), Placebo |
| NCT00470665 Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients | Renal Allograft Recipients | P3 | Completed | 460 | RCT, Open-label | Rapamune |
| NCT00252967 Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF) | Atrial Fibrillation, Inflammation | P3 | Terminated | 64 | RCT, Double-blind | Atorvastatin, Placebo |
| NCT01008605 Caverject User Study | Erectile Dysfunction | P3 | Completed | 48 | Open-label | — |
| NCT00500357 Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects | Vaccines, Pneumococcal Conjugate Vaccine | P3 | Completed | 105 | Open-label | 13-valent Pneumococcal Conjugate Vaccine |
| NCT05632354 GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD) | Sickle Cell Disease | P2P3 | Terminated | 47 | Open-label | Osivelotor |
| NCT01232556 A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy | Lymphoma, Non-Hodgkin | P3 | Terminated | 338 | RCT, Open-label | Inotuzumab ozogamicin, Rituximab, rituximab + gemcitabine, rituximab +bendamustine |
| NCT01500551 Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis | Juvenile Idiopathic Arthritis | P2P3 | Completed | 302 | Open-label | Tofacitinib, Tofacitinib |
| NCT04218084 Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease | Sickle Cell Disease | P3 | Terminated | 236 | RCT, Double-blind | Voxelotor, Placebo |
| NCT01360372 Effect of Methylnaltrexone (Relistor) on Digestion and Tolerance to Tube Feeding in Patients Treated With Opiates | Tube Feeding | P3 | Withdrawn | — | RCT, Double-blind | Methylnaltrexone, Saline injection |
| NCT07300839 A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age | COVID-19, SARS-COV-2 Infection | P3 | Completed | 5,240 | RCT, Double-blind | BNT162b2 Vaccine, Placebo |
| NCT01309737 A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis | Psoriasis | P3 | Completed | 960 | RCT, Double-blind | CP-690,550, CP-690,550, Placebo/CP-690,550, Placebo/CP-690,550 |
| NCT00650637 A Study to Determine Effective Prophylaxis and Treatment of Nelfinavir-Associated Diarrhea | Diarrhea | P3 | Terminated | 17 | RCT, Open-label | Calcium Carbonate, nelfinavir, lamivudine, loperamide, nelfinavir, lamivudine + zidovudine |
| NCT01169467 Cerebral Perfusion Pressure Using Precedex and Other Sedatives | Endotracheal Intubation, Continuous IV Sedation | P3 | Completed | 89 | RCT, Double-blind | Standard-of-Care plus Dexmedetomidine |
| NCT02718417 Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100) | Ovarian Cancer | P3 | Terminated | 998 | RCT, Open-label | carboplatin, paclitaxel, Avelumab, Avelumab |
| NCT03235479 Safety and Efficacy Study in Adult Subjects With Acute Migraines | Migraine, With or Without Aura | P3 | Completed | 1,485 | RCT, Double-blind | Rimegepant, Placebo |
| NCT05997290 A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals | SARS-CoV-2 Infection, COVID-19 | P2P3 | Completed | 1,051 | Open-label | BNT162b2 (Omi XBB.1.5), BNT162b2 (Omi JN.1), BNT162b2 (Omi KP.2) |
| NCT03796676 JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis | Atopic Dermatitis | P3 | Completed | 287 | RCT, Double-blind | Placebo, PF-04965842, PF04965842 |
| NCT00161876 FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years | Encephalitis, Tick-borne | P3 | Completed | 3,973 | Open-label | Tick-Borne Encephalitis (TBE) Vaccine (Inactivated) |
| NCT01806623 The Study Of Fluconazole For Vulvovaginal Candidiasis | Vulvovaginal Candidiasis | P3 | Completed | 157 | Open-label | Fluconazole |
| NCT00174382 Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia | Dementia, Vascular, Dementia, Mixed | P3 | Terminated | 149 | Open-label | Donepezil |
| NCT01968954 Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events | Hyperlipidemia | P3 | Completed | 711 | RCT, Double-blind | Bococizumab (PF-04950615;RN316) |
| NCT00134173 A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease | Coronary Disease, Coronary Arteriosclerosis | P3 | Completed | 1,100 | RCT, Double-blind | torcetrapib/atorvastatin, atorvastatin |
| NCT00138723 Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder Syndrome | Overactive Bladder | P3 | Completed | — | RCT, Double-blind | SPM 907 |
| NCT03732807 PF-06651600 for the Treatment of Alopecia Areata | Alopecia Areata | P2P3 | Completed | 718 | RCT, Double-blind | PF-06651600 Induction Dose, PF-06651600 Maintenance Dose #1, PF-06651600 Maintenance Dose #2, PF-06651600 Maintenance Dose #3, Placebo |
| NCT00205777 Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women | Osteoporosis | P3 | Completed | 7,609 | RCT, Double-blind | Bazedoxifene Acetate |
| NCT03573882 Study to Assess the Effect of Long-term Treatment With Voxelotor in Participants Who Have Completed Treatment in Study GBT440-031 | Sickle Cell Disease | P3 | Terminated | 179 | Open-label | Voxelotor |
| NCT02528253 A Phase 3 Study of Tanezumab for Chronic Low Back Pain | Low Back Pain | P3 | Completed | 1,832 | RCT, Double-blind | Placebo to Week 16; tanezumab 5mg SC, Placebo to Week 16, tanezumab 10 mg SC, Tanezumab 5 mg SC, Tanezumab 10 mg SC, Tramadol PR oral |
| NCT00285012 Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD). | Smoking Cessation | P3 | Completed | 504 | RCT, Double-blind | placebo, Varenicline Tartarate |
| NCT00432796 PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin. | Stroke | P3 | Unknown | 1,473 | RCT, Double-blind | Dalteparin |
| NCT00163527 Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013) | Asthma | P3 | Completed | 2,054 | RCT, Double-blind | Roflumilast |
| NCT00546572 Study Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) | Pneumococcal Infections | P3 | Completed | 938 | RCT, Double-blind | 13 valent Pneumococcal Conjugate Vaccine, 23vPS |
| NCT00391196 A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients | Obesity | P3 | Terminated | 975 | RCT, Double-blind | Placebo, CP-945,598, CP-945,598 Treatment B |
| NCT00788177 Subretinal Macugen® for Neovascular Age-Related Macular Degeneration | Age-related Macular Degeneration | P3 | Unknown | 10 | Open-label | Pegaptanib (Macugen®) |
| NCT00795639 Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS) | Pulmonary Arterial Hypertension, Pulmonary Hypertension | P3 | Terminated | 183 | RCT, Double-blind | Sitaxsentan, Placebo |
| NCT00496769 A Phase III Study of Apixaban in Patients With Atrial Fibrillation | Atrial Fibrillation | P3 | Completed | 6,421 | RCT, Double-blind | Apixaban, Acetylsalicylic acid |
| NCT00355589 Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension | Hypertension, Blood Pressure, High | P3 | Completed | — | RCT, Double-blind | Ramipril and hydrochlorothiazide |
| NCT00527397 Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes | Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1 | P3 | Terminated | 24 | Open-label | CP-464,005, CP-464,005, CP-464,005 |
| NCT01975389 The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects | Cardiovascular Disease | P3 | Terminated | 10,564 | RCT, Double-blind | bococizumab (PF-04950615), Placebo |
| NCT01241591 A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis | Psoriasis | P3 | Completed | 1,101 | RCT, Double-blind | CP 690,550 5 mg, CP 690,550 10 mg, Etanercept 50 mg |
| NCT00627003 A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLS | Restless Legs Syndrome | P3 | Completed | 43 | RCT, Double-blind | Cabergoline |
| NCT01882439 Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors | Psoriatic Arthritis | P3 | Completed | 395 | RCT, Double-blind | Tofacitinib, Tofacitinib, Tofacitinib, Tofacitinib |
| NCT00256685 Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause | Menopause, Hot Flashes | P3 | Completed | 568 | RCT, Double-blind | DVS-233 SR |
| NCT00868296 Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD) | Gastroesophageal Reflux | P3 | Completed | 58 | Open-label | pantoprazole |
| NCT01438918 X-Ray Study Investigating The Safety And Efficacy Of SD-6010 In Subjects With Osteoarthritis Of The Knee | Knee Osteoarthritis | P3 | Withdrawn | — | RCT, Double-blind | SD-6010, SD-6010, Placebo |
| NCT00150267 A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension | Glaucoma, Open-Angle, Ocular Hypertension | P3 | Completed | 976 | Open-label | Xalacom |
| NCT04713553 A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants | SARS-CoV-2 Infection, COVID-19 | P3 | Completed | 1,574 | RCT, Double-blind | BNT162b2, BNT162b2.B.1.351 |
| NCT00643734 A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients | Pneumonia | P3 | Completed | 468 | RCT, Double-blind | azithromycin sustained release, levofloxacin |
| NCT03423199 PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY | Breast Neoplasms | P3 | Unknown | 180 | RCT, Double-blind | Palbociclib, Placebo, Tamoxifen, Goserelin |
| NCT00625872 Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy | Growth Hormone Therapy, Infant, Small for Gestational Age | P3 | Terminated | 23 | RCT, Open-label | Somatropin, Somatropin |
| NCT00161928 Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants | Meningitis, Meningococcal | P3 | Completed | 330 | RCT, Open-label | Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine (GCMP-TT) |
| NCT01112865 Cross Over Convenience And Preference Study Of New Mark VII Compared To Genotropin Pen In Pediatric And Adult Subjects | Growth Hormone Deficiency | P3 | Completed | 120 | RCT, Open-label | — |
| NCT00675688 Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women | Endometrial Hyperplasia, Osteoporosis | P3 | Completed | 3,544 | RCT, Double-blind | Bazedoxifene/Conjugate Estrogens (CE), Raloxifene, Placebo |
| NCT00645242 A Study Of Diflucan In Children With Ringworm Of The Scalp | Tinea Capitis | P3 | Completed | 185 | Open-label | fluconazole |
| NCT01033760 Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM) | HIV-1 Infections | P3 | Completed | 90 | RCT, Open-label | raltegravir; maraviroc; darunavir; ritonavir; tenofovir/emtricitabine, darunavir; ritonavir; emtricitabine/tenofovir |
| NCT00471146 Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. | Carcinoma, Pancreatic Ductal | P3 | Completed | 630 | RCT, Double-blind | AG-013736, Gemcitabine, Gemcitabine, placebo |
| NCT00192283 Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold- Adapted (CAIV-T) in Healthy Children Attending Day Care Centers | Influenza | P3 | Completed | 2,903 | RCT, Double-blind | CAIV-T |
| NCT04230213 A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis | Rheumatoid Arthritis | P3 | Completed | 455 | RCT, Open-label | PF-06410293, adalimumab |
| NCT00134238 Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin. | Mixed Hyperlipidemia | P3 | Terminated | 755 | RCT, Double-blind | torcetrapib/atorvastatin, atorvastatin |
| NCT00754221 Open Label Extension Study of [S,S]-Reboxetine in Patients With Fibromyalgia | Fibromyalgia | P3 | Terminated | 390 | Open-label | [S,S]-Reboxetine |
| NCT00038311 Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia | Sarcoma | P3 | Completed | 120 | RCT, Double-blind | PN-152,243)/PN-196,444 |
| NCT00856544 A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis Medications | Arthritis, Rheumatoid | P3 | Completed | 795 | RCT, Double-blind | CP-690,550, CP-690,550, Placebo, Placebo |
| NCT01229436 Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex) | Dupuytren's Contracture | P3 | Completed | 254 | Open-label | Xiapex |
| NCT01120028 Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy | Kidney Transplantation | P2P3 | Completed | 852 | RCT, Open-label | Alemtuzumab, Basiliximab, Sirolimus, Tacrolimus |
| NCT01345630 Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1 | HIV-1 | P3 | Terminated | 813 | RCT, Double-blind | Maraviroc, Emtricitabine/tenofovir, darunavir/ritonavir 800/100 mg, placebo for emtricitabine/tenofovir, placebo for maraviroc |
| NCT01808092 A Study Comparing Ceftazidime-Avibactam Versus Meropenem in Hospitalized Adults With Nosocomial Pneumonia | Nosocomial Pneumonia (NP), Ventilator-associated Pneumonia (VAP) | P3 | Completed | 969 | RCT, Double-blind | ceftazidim-avibactam (CAZ-AVI, experimental product), meropenem (active comparator) |
| NCT01634139 Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma | Asthma | P3 | Completed | 403 | RCT, Double-blind | Tiotropium low dose QD, Tiotropium high dose QD, Placebo |
| NCT00134264 A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease | Coronary Disease, Diabetes Mellitus | P3 | Terminated | 15,067 | RCT, Double-blind | torcetrapib/atorvastatin, atorvastatin |
| NCT01127893 Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis | Osteoarthritis | P3 | Terminated | 1 | RCT, Double-blind | Tanezumab, Tanezumab, Tanezumab |
| NCT00150436 To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia. | Neuralgia | P3 | Completed | 276 | Open-label | Pregabalin |
| NCT00651300 A Study of the Recovery Benefits After Treatment With Parecoxib/Valdecoxib in Patients Undergoing Abdominal Surgery | Pain | P3 | Terminated | 91 | RCT, Double-blind | Parecoxib/Valdecoxib, Placebo |
| NCT00920816 Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer | Kidney Neoplasms | P3 | Completed | 492 | RCT, Open-label | Axitinib (AG-013736), Sorafenib |
| NCT05011513 Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). | COVID-19 | P2P3 | Terminated | 1,440 | RCT, Double-blind | PF-07321332, Ritonavir, Placebo, Placebo |
| NCT00373113 A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine | Breast Neoplasms | P3 | Terminated | 482 | RCT, Open-label | Capecitabine, Sunitinib malate |
| NCT00137410 Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee | Osteoarthritis,Knee | P3 | Completed | 200 | RCT, Double-blind | Celebrex |
| NCT00007735 Antibiotic Treatment of Gulf War Veterans' Illnesses | Persian Gulf Syndrome, Mycoplasma Infections | P3 | Completed | 450 | RCT, Double-blind | Doxycycline (200mg/day) or Placebo |
| NCT00743652 Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children. | Pneumococcal Disease, 13-valent Pneumococcal Vaccine | P3 | Completed | 373 | Open-label | 13-valent Pneumococcal Conjugate Vaccine, 13-valent Pneumococcal Conjugate Vaccine, 13-valent Pneumococcal Conjugate Vaccine, 13-valent Pneumococcal Conjugate Vaccine, 13-valent Pneumococcal Conjugate Vaccine |
| NCT00963235 Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS | HIV Infections, Pneumococcal Infections | P3 | Completed | 331 | Open-label | 13-valent pneumococcal conjugate vaccine |
| NCT00075218 A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST) | Gastrointestinal Stromal Tumor | P3 | Completed | 361 | RCT, Double-blind | Placebo, SU011248 |
| NCT00266851 AZMATICS: AZithroMycin/Asthma Trial In Community Settings | Asthma | P3 | Completed | 97 | RCT, Double-blind | Azithromycin, Placebo |
| NCT00300378 Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder | Depressive Disorder, Major | P3 | Completed | 480 | RCT, Double-blind | desvenlafaxine 50 mg, desvenlafaxine 100 mg |
| NCT00643136 A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures | Sleep Deprivation, Epilepsies, Partial | P3 | Completed | 17 | RCT, Double-blind | Pregabalin, Placebo |
| NCT00141336 To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. | Seizure Disorder, Partial | P3 | Completed | 750 | Open-label | Pregabalin |
| NCT00137371 Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis | Atrophic Vaginitis, Atrophy | P3 | Completed | 480 | RCT, Double-blind | PVC (daily for 21 days, 7 days off), PVC (twice weekly) |
| NCT00141167 A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo for Smoking Cessation | Smoking Cessation | P3 | Completed | 250 | RCT, Double-blind | varenicline |
| NCT00321997 A Clinical Trial to Explore Safety and Efficacy of Different Doses of Pegaptanib Sodium, Compared to Sham, in Patients With Wet AMD. | Age-Related Macular Degeneration | P2P3 | Completed | 540 | RCT, Double-blind | Pegaptanib sodium |
| NCT01210443 Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients | Hypertension, Pulmonary | P3 | Terminated | 2 | Open-label | Sitaxentan |
| NCT01975376 The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects | Cardiovascular Disease | P3 | Terminated | 16,784 | RCT, Double-blind | bococizumab (PF-04950615), Placebo |
| NCT01942135 Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) | Metastatic Breast Cancer | P3 | Completed | 521 | RCT, Double-blind | Palbociclib, Fulvestrant, Placebo, Fulvestrant |
| NCT01058642 Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia | Postherpetic Neuralgia | P2 | Terminated | 41 | RCT, Double-blind | ADL5747, Placebo, Pregabalin |
| NCT00425256 Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD) | Sexual Arousal Disorder | P2 | Completed | — | RCT, Double-blind | Bremelanotide |
| NCT02400567 Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women | Neoadjuvant Operable Breast Cancer | P2 | Completed | 125 | RCT, Open-label | Fluorouracile, Epirubicin, Cyclophosphamide, Letrozole, Palbociclib |
| NCT01062113 Study To Evaluate Efficacy And Safety Of An Additional Dose Of Celecoxib (YM177) In Patients With Post-Tooth Extraction Pain | Pain | P2 | Completed | 255 | RCT, Double-blind | Celecoxib, Celecoxib, Placebo |
| NCT00636246 A Comparison of Sertraline-reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression. | Depressive Disorder, Major | P2 | Completed | 510 | RCT, Double-blind | sertraline/[S,S]-reboxetine, sertraline/[S,S]-reboxetine, sertraline, sertraline, sertraline/[S,S]-reboxetine, Placebo, sertraline/[S,S]-reboxetine, [S,S]-reboxetine monotherapy |
| NCT01281917 Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma | Non-Hodgkins Lymphoma | P2 | Completed | 40 | Open-label | Velcade, Temsirolimus |
| NCT04569032 A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression | Peripheral T-cell Lymphoma | P2 | Completed | 82 | Open-label | brentuximab vedotin, cyclophosphamide, doxorubicin, prednisone |
| NCT03054363 Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer | Breast Cancer | P1P2 | Completed | 42 | RCT, Open-label | Tucatinib in Combination with Palbociclib and Letrozole, Tucatinib in Combination with Palbociclib and Letrozole |
| NCT01547299 Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer | Prostate Cancer | P2 | Completed | 52 | RCT, Open-label | Enzalutamide, Leuprolide, Dutasteride |
| NCT05574010 A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it) | Celiac Disease | P1P2 | Terminated | 128 | RCT, Double-blind | Cohort 1 in Part A, Cohort 2 in Part A, Group 2 in Part B and Part C, Group 3 in Part B and Part C, Group 4 in Part B and Part C |
| NCT01069861 Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN) | PPHN, Persistent Pulmonary Hypertension of the Newborn | P2 | Terminated | 4 | Open-label | sildanefil |
| NCT01379144 A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension | Primary Open Angle Glaucoma, Ocular Hypertension | P2 | Completed | 282 | RCT, Double-blind | latanoprost 75 ug, latanoprost 100 ug, latanoprost 125 ug, latanoprost 50 ug |
| NCT00570128 Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome | Down Syndrome | P2 | Completed | 129 | RCT, Double-blind | Donepezil HCl, Placebo |
| NCT03628066 Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer | Breast Cancer | P2 | Completed | 24 | Open-label | Letrozole, Palbociclib, Goserelin |
| NCT00746967 An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder | Sexual Dysfunctions, Psychological, Sexual Arousal Disorder | P2 | Completed | 267 | Open-label | sildenafil |
| NCT02384382 A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC) | Prostate Carcinoma Metastatic to the Bone, Castration Resistant Prostate Cancer | P2 | Completed | 23 | Open-label | Enzalutamide |
| NCT00143429 Corneal Versus Conjunctival Delivery Using a Delivery Device | Glaucoma, Open-Angle, Ocular Hypertension | P2 | Withdrawn | — | RCT, Single-blind | Xalatan |
| NCT00483262 Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma | Multiple Myeloma | P1P2 | Completed | 63 | Open-label | CCI-779, Bortezomib |
| NCT02921919 Open-Label Extension and Safety Study of Talazoparib | Cancer | P2 | Completed | 120 | Open-label | Talazoparib |
| NCT05471492 Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's Disease | Crohn Disease | P2 | Withdrawn | — | RCT, Double-blind | Investigational Product, Placebo |
| NCT00006399 Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease | Alzheimer Disease | P2 | Completed | 45 | Double-blind | Donepezil, Estrogen, Progesterone |
| NCT03409458 A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab | Non-Small Cell Lung Cancer (NSCLC) | P1P2 | Completed | 68 | Open-label | PT-112, avelumab |
| NCT00640458 Study to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (MRI) in Pre-menopausal Women With Female Sexual Arousal Disorder | Female Sexual Arousal Disorder | P2 | Completed | 20 | RCT, Double-blind | Sildenafil 100 mg, Placebo |
| NCT04824937 Telaglenastat + Talazoparib In Prostate Cancer | Prostate Cancer Metastatic | P2 | Withdrawn | — | Open-label | Telaglenastat, Talazoparib |
| NCT00993148 Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1 | HIV-1 Infection, HIV Infections | P2 | Completed | 25 | Open-label | maraviroc, darunavir, ritonavir |
| NCT01889238 Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer | Advanced, Androgen Receptor Positive Triple Negative Breast Cancer | P2 | Completed | 118 | Open-label | Enzalutamide |
| NCT01030406 Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid Users | Opioid Abuse | P2 | Completed | 49 | RCT, Double-blind | 40/0mg taken first, 80/0mg taken first, 40/240mg taken first, 80/480mg taken first, 0/0mg taken first |
| NCT00640146 Study of Subcutaneous Methylnaltrexone (MNTX) in the Treatment of Opioid-Induced Constipation During Rehabilitation After Orthopedic Procedures | Opioid-induced Constipation | P2 | Completed | 37 | RCT, Double-blind | Methylnaltrexone bromide, Placebo |
| NCT06125522 TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C) | Breast Cancer | P1P2 | Terminated | 11 | Open-label | vepdegestrant, Samuraciclib |
| NCT00548717 Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation | Graft-vs-Host Disease | P2 | Terminated | 15 | Open-label | Sirolimus, Mycophenolate mofetil, Bortezomib |
| NCT00354978 Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients | Colorectal Cancer | P2 | Completed | 49 | Open-label | 5-Fluorouracil, Bevacizumab, Leucovorin, Irinotecan |
| NCT01284920 A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients | Prostate Cancer, Prostate Neoplasms | P1P2 | Completed | 47 | Open-label | MDV3100 |
| NCT02124668 A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy | Castration-Resistant Prostate Cancer, Prostate Cancer | P2 | Completed | 30 | Open-label | Enzalutamide |
| NCT00437281 Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures | Epilepsies, Partial | P1P2 | Completed | 65 | RCT, Double-blind | Placebo, Pregabalin |
| NCT04849364 Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer | Breast Cancer, Triple Negative Breast Cancer | P2 | Terminated | 52 | Open-label | Capecitabine, Talazoparib, Pembrolizumab, Inavolisib |
| NCT04072952 A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Participants With ER+/HER2- Locally Advanced or Metastatic Breast Cancer | Breast Cancer | P1P2 | Completed | 219 | Open-label | Vepdegestrant, Vepdegestrant, Palbociclib |
| NCT02841267 A Trial of PF-06252616 in Ambulatory Participants With LGMD2I | LGMD2I | P1P2 | Completed | 19 | Open-label | PF 06252616 |
| NCT06001177 A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease | Celiac Disease, Coeliac Disease | P2 | Completed | 55 | RCT, Double-blind | KAN-101, Placebo |
| NCT00650611 A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders | Schizophrenia, Bipolar Disorder | P2 | Completed | 63 | RCT, Open-label | Ziprasidone, Ziprasidone |
| NCT04690855 A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer | Breast Cancer, Triple Negative Breast Cancer | P2 | Terminated | 1 | Open-label | Talazoparib, Atezolizumab |
| NCT02528643 A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma | Advanced Hepatocellular Carcinoma | P2 | Completed | 165 | RCT, Double-blind | Enzalutamide, Placebo |
| NCT00245609 Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure | Dental Anxiety | P2 | Completed | 90 | RCT, Double-blind | Pregabalin, Alprazolam, Placebo |
| NCT01288911 A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer | Prostatic Neoplasms | P2 | Completed | 375 | RCT, Double-blind | enzalutamide, bicalutamide |
| NCT05007821 Linezolid Dosing Strategies in Drug-Resistant TB | Tuberculosis, Multidrug-Resistant, Tuberculosis | P2 | Completed | 138 | RCT, Open-label | Linezolid 600 mg, Linezolid 1200 mg (QD), Linezolid 1200 mg (TIW), Bedaquiline 200 mg, Bedaquiline 100 mg, Delamanid 300 mg, Clofazimine 300 mg, Clofazimine 100 mg |
| NCT02007512 Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer | Breast Cancer | P2 | Completed | 247 | RCT, Double-blind | Enzalutamide, exemestane, Placebo (for enzalutamide), exemestane |
| NCT00141310 Sildenafil Citrate for the Treatment of Established Pre-Eclampsia | Pre-eclampsia | P2 | Terminated | 76 | RCT, Double-blind | Sildenafil citrate |
| NCT01091103 Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide | Metastatic Progressive Castration-resistant Prostate Cancer | P2 | Completed | 60 | Open-label | Enzalutamide |
| NCT02296801 A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer | Breast Cancer, Breast Carcinoma | P2 | Completed | 307 | RCT, Open-label | Letrozole, palbociclib |
| NCT00634933 Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis | Arthritis, Rheumatoid | P2 | Terminated | 222 | RCT, Double-blind | TRU-015, Methylprednisolone, Prednisone, TRU-015, Methylprednisolone, Prednisone, TRU-015, Methylprednisolone, Prednisone |
| NCT01650194 A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients | Metastatic Castration-Resistant Prostate Cancer | P2 | Completed | 60 | Open-label | enzalutamide, abiraterone acetate, prednisone |
| NCT00675025 Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial | Down Syndrome | P2 | Terminated | 117 | Open-label | Donepezil hydrochloride (Aricept) |
| NCT01534052 A Study to Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100 | Castration-Resistant Prostate Cancer (CRPC) | P2 | Completed | 52 | Open-label | Enzalutamide |
| NCT01360671 IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn | Persistent Pulmonary Hypertension of the Newborn | P2 | Withdrawn | — | Open-label | Sildenafil |
| NCT07782450 A Study to Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases | Systemic Lupus Erythematosus, Rheumatoid Arthritis | P1P2 | Not Yet Recruiting | 54 | Open-label | PF-08154225 |
| NCT01122680 Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma | Asthma | P2 | Completed | 105 | RCT, Double-blind | Tiotropium bromide, tiotropium bromide, tiotropium bromide, Placebo |
| NCT00037180 For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy | Neoplasm Metastasis, Colorectal Neoplasms | P2 | Terminated | 212 | RCT, Double-blind | Celecoxib, Irinotecan, 5-fluorouracil, Leucovorin |
| NCT00559910 A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD). | Chronic Obstructive Pulmonary Disease | P2 | Completed | 230 | RCT, Double-blind | PH-797804, Placebo |
| NCT03472560 A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF) | Non-Small Cell Lung Cancer, Urothelial Cancer | P2 | Terminated | 61 | Open-label | Avelumab (MSB0010718C), Axitinib (AG-013736) |
| NCT00205803 Study Evaluating Pneumococcal Vaccine in Healthy Infants | Healthy Subjects, Pneumococcal Infections | P1P2 | Completed | 249 | RCT, Double-blind | 13-Valent Pneumococcal Conjugate Vaccine (13vPnC), 7-Valent Pneumococcal Conjugate Vaccine (7vPnC) |
| NCT01693822 A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy | Clear-cell Metastatic Renal Cell Carcinoma | P2 | Completed | 65 | Open-label | Axitinib |
| NCT02255227 Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD | Infections, Pneumococcal, Bowel Diseases, Inflammatory | P2 | Terminated | 104 | RCT, Open-label | Prevenar 13, Pneumo 23 |
| NCT00004861 Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer | Pancreatic Cancer | P2 | Completed | — | RCT | gemcitabine hydrochloride, tacedinaline |
| NCT00323986 Azithromycin Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) and Tracheostomy | COPD, Tracheostomy | P2 | Terminated | 30 | RCT, Open-label | azithromycin (drug) |
| NCT03258502 A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) Infection | Respiratory Syncytial Virus Infections | P2 | Completed | 66 | RCT, Double-blind | RV521, Placebo |
| NCT01517373 Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin | Diabetes Mellitus, Type 2 | P2 | Completed | 304 | RCT, Double-blind | Placebo, PF-04937319 10 mg, PF-04937319 50 mg, PF-04937319 100 mg, Glimepiride |
| NCT00192166 Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months | Influenza | P2 | Completed | 1,200 | RCT, Double-blind | CAIV-T |
| NCT00959946 Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer | Advanced Breast Cancer (Parts 1 and 2), Advanced Pancreatic Cancer (Part 1) | P1P2 | Terminated | 32 | Open-label | Bosutinib, Capecitabine |
| NCT06821061 A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People | Influenza, COVID-19 (Coronavirus Disease 2019) | P1P2 | Completed | 2,650 | RCT, Double-blind | Investigational Influenza Vaccine, Investigational COVID-19 Vaccine, Licensed Influenza Vaccine 1, Licensed Influenza Vaccine 2, Licensed Influenza Vaccine 3, Licensed COVID-19 Vaccine |
| NCT04766086 Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women | Group B Streptococcus Infections | P2 | Completed | 306 | RCT, Double-blind | Multivalent Group B streptococcus vaccine, Tetanus, diphtheria, and acellular pertussis vaccine, Placebo |
| NCT00930059 A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease | Alzheimer's Disease | P2 | Completed | 191 | RCT, Double-blind | PF-04447943, Placebo |
| NCT00615056 A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen | Colorectal Neoplasms | P2 | Completed | 171 | RCT, Open-label | Bevacizumab (avastin), FOLFIRI (Irinotecan, leucovorin, 5-fluorouracil [5FU]), AG-013736 (axitinib), FOLFOX (oxaliplatin, leucovorin, 5-fluorouracil [5FU]), AG-013736 (axitinib), FOLFIRI (irinotecan, leucovorin, 5-fluorouracil [5FU]), Bevacizumab (avastin), FOLFOX (oxaliplatin, leucovorin, 5-fluorouracil [5FU]) |
| NCT00553254 Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer | Carcinoma, Non Small Cell Lung | P2 | Completed | 55 | Open-label | PF-00299804 |
| NCT01927341 Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS Tumors | Metastatic Colorectal Cancer | P1P2 | Completed | 53 | Open-label | MEK162, Panitumumab |
| NCT01393639 Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis | Rheumatoid Arthritis | P2 | Completed | 323 | RCT, Double-blind | PF-04171327, PF-04171327, PF-04171327, PF-04171327, prednisone |
| NCT00696787 A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia | Fibromyalgia | P2 | Terminated | 125 | RCT, Double-blind | Desvenlafaxine Sustained Release (DVS SR), Lyrica® (Pregabalin), Placebo |
| NCT00482664 The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women With Female Sexual Arousal Disorder. | Sexual Dysfunction, Physiological | P2 | Completed | 84 | RCT, Double-blind | CP-866,087, CP-866,087, CP-866,087, Placebo |
| NCT00479492 Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers | Obesity | P2 | Completed | 94 | RCT, Double-blind | CP-866,087, CP-866,087, CP-866,087, placebo |
| NCT01211275 Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma | Malignant Pleural Mesothelioma | P1P2 | Completed | 32 | RCT, Open-label | axitinib, chemotherapy |
| NCT00037219 The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis. | Candidiasis | P2 | Completed | 120 | Open-label | Anidulafungin, VER002 |
| NCT00823979 A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1 | HIV-1 | P2 | Terminated | 105 | RCT, Double-blind | UK-453,061 Dose 1, UK-453,061 Dose 2, Etravirine |
| NCT01649180 NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma | Renal Cell Carcinoma | P2 | Terminated | 3 | Open-label | Axitinib |
| NCT00606008 A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma | Anaplastic Astrocytoma, Glioblastoma | P2 | Completed | 30 | Open-label | Sunitinib Malate |
| NCT04225897 A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection. | Respiratory Syncytial Virus (RSV), Lower Resp Tract Infection | P2 | Terminated | 51 | RCT, Double-blind | RV521, Placebo |
| NCT05038982 Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin | Prurigo Nodularis, Pruritus | P2 | Completed | 20 | Open-label | Abrocitinib |
| NCT02055976 Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects | Hypercholesterolemia | P2 | Completed | 218 | RCT, Double-blind | Bococizumab (PF-04950615;RN316), Bococizumab (PF-04950615;RN316), Bococizumab (PF-04950615;RN316), Placebo, Ezetimibe, Bococizumab (PF-04950615;RN316), Bococizumab (PF-04950615;RN316), Bococizumab (PF-04950615;RN316), Placebo |
| NCT01331291 Bosutinib in Adult Patients With Recurrent Glioblastoma | Glioblastoma | P2 | Completed | 36 | Open-label | bosutinib |
| NCT03693170 Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer | BRAF V600E-mutant Metastatic Colorectal Cancer | P2 | Completed | 95 | Open-label | encorafenib, Binimetinib, Cetuximab |
| NCT03530696 T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer | HER2-positive Breast Cancer, Breast Cancer | P2 | Completed | 55 | RCT, Open-label | Palbociclib, T-DM1 |
| NCT00550446 A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis | Arthritis, Rheumatoid | P2 | Completed | 386 | RCT, Double-blind | Adalimumab, CP-690-550, CP-690-550, CP-690-550, CP-690,550, CP-690,550, Placebo |
| NCT01246583 CP-690-550 Ointment For Chronic Plaque Psoriasis | Psoriasis | P2 | Completed | 71 | RCT, Double-blind | CP-690,550 Ointment 1, Vehicle 1, CP-690,550 Ointment 2, Vehicle 2 |
| NCT00830427 A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects | Asthma, Bronchial, Lung Diseases, Obstructive | P2 | Withdrawn | — | RCT, Single-blind | PF-00610355, PF - 00610355, PF - 00610355 |
| NCT07672782 Tisotumab Vedotin in Squamous Cell Carcinoma of the Vulva | Vulvar Carcinoma, Recurrent or Metastatic Vulvar Cancer | P2 | Not Yet Recruiting | 28 | Open-label | Tisotumab Vedotin |
| NCT01096667 Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042) | Diabetes Mellitus, Type 2, Hypertension | P2 | Completed | 194 | RCT, Double-blind | Placebo to Ertuglilflozin 1 or 5 mg, Ertugliflozin 1 mg, Ertugliflozin 5 mg, Ertugliflozin 25 mg, HCTZ 12.5mg, Placebo to HCTZ, Placebo to ertuglilflozin 25 mg |
| NCT02109445 Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies | Metastatic Cancer Pancreas | P2 | Terminated | 3 | RCT, Open-label | PF-03084014, Gemcitabine, Nab-paclitaxel, PF-03084014, Gemcitabine, Nab-paclitaxel, Gemcitabine, Nab-paclitaxel |
| NCT00569972 A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia | Insomnia | P2 | Completed | 682 | RCT, Double-blind | PD 0200390, PD 0200390, PD 0200390, PD 0200390, Placebo |
| NCT00895895 Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease | Alzheimer Disease | P2 | Terminated | 526 | RCT, Double-blind | Placebo, SAM-531 1.5 mg, SAM-531 3.0 mg, SAM-531 5.0 mg, Donepezil |
| NCT00961571 Sunitinib and Capecitabine for First Line Colon Cancer | Metastatic Colorectal Cancer | P2 | Terminated | 50 | Open-label | sunitinib and capecitabine |
| NCT00652028 Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects | Intubated and Mechanically Ventilated Pediatric Subjects | P2 | Completed | 69 | Open-label | Dexmedetomidine, midazolam; fentanyl |
| NCT00752557 Study Evaluating Changes In Bone Mineral Density (BMD), And Safety Of Rhbmp-2/CPM In Subjects With Decreased BMD | Osteoporosis | P2 | Completed | 50 | RCT, Double-blind | rhBMP-2/CPM injection and bisphosphonates, calcium, and vitamin D (oral bisphosphonate therapy), rhBMP-2/CPM injection and bisphosphonates, calcium, and vitamin D (oral bisphosphonate therapy), bisphosphonates, calcium, and vitamin D |
| NCT04785612 Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults | Respiratory Syncytial Virus Infections | P2 | Completed | 70 | RCT, Double-blind | RSVPreF |
| NCT03400254 Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER") | Breast Cancer | P1P2 | Withdrawn | — | RCT, Single-blind | Hydroxychloroquine (HCQ), Gedatolisib |
| NCT01087203 A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy | Diabetic Peripheral Neuropathy | P2 | Terminated | 73 | RCT, Double-blind | Tanezumab, placebo |
| NCT03341845 Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC | Renal Cell Carcinoma | P2 | Unknown | 40 | Open-label | Axitinib, Avelumab |
| NCT05070845 Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia | Primary Immune Thrombocytopenia | P2 | Terminated | 61 | Open-label | PF-06835375 |
| NCT00062751 Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms | Breast Neoplasms | P2 | Completed | 108 | RCT, Open-label | Letrozole / Temsirolimus (CCI-779), Letrozole / Temsirolimus (CCI-779), Letrozole |
| NCT01730339 Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery | Reduction of Hypertrophic Skin Scarring | P2 | Completed | 103 | RCT, Double-blind | PF-06473871, PF-06473871 |
| NCT00265317 A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone | Carcinoma, Non-Small-Cell Lung | P2 | Completed | 162 | RCT, Double-blind | erlotinib, sunitinib, erlotinib, placebo |
| NCT00787202 A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis. | Ulcerative Colitis | P2 | Completed | 195 | RCT, Double-blind | CP- 690 550, CP- 690 550, CP- 690 550, CP- 690 550 |
| NCT03895372 A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis | Psoriasis | P2 | Completed | 179 | RCT, Double-blind | PF-06826647 or Placebo, PF-06826647 |
| NCT01059825 Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016) | Diabetes Mellitus, Type 2 | P2 | Completed | 375 | RCT, Double-blind | Placebo to Ertugliflozin, Ertugliflozin 1 mg, Ertugliflozin 5 mg, Ertugliflozin 25 mg, Sitagliptin 100 mg, Placebo to Sitagliptin, Metformin |
| NCT00916617 Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab | Alzheimer Disease | P2 | Terminated | 62 | Open-label | bapineuzumab |
| NCT03769194 Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study. | Lyme Borreliosis | P2 | Completed | 572 | RCT, Double-blind | VLA15, Placebo |
| NCT00615199 A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease | Crohn's Disease | P2 | Completed | 139 | RCT, Double-blind | CP-690,550, CP-690,550, CP-690,550, Placebo |
| NCT04321031 Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) | Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis With Liver Fibrosis | P2 | Completed | 256 | RCT, Double-blind | Placebo, PF-06865571, PF-05221304 |
| NCT06897202 A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM | Obesity in Diabetes, Type 2 Diabetes Mellitus (T2DM) | P2 | Completed | 133 | RCT, Double-blind | MET097 Injection, Placebo |
| NCT01577381 Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration | Age-Related Maculopathy | P2 | Terminated | 10 | RCT, Double-blind | RN6G, Placebo |
| NCT00678782 Evaluation of The Efficacy And Safety of Intra-Articular Etanercept in Patients With Refractory Knee Joint Synovitis | Persistent Knee Joint Synovitis | P2 | Completed | 31 | RCT, Single-blind | etanercept, placebo |
| NCT00496223 A Phase I/II Study of Sunitinib and Dacarbazine | Melanoma | P1P2 | Terminated | 11 | Open-label | Sunitinib, Dacarbazine |
| NCT00589784 Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma | CNS Cancer, Meningioma | P2 | Completed | 50 | Open-label | Sunitinib |
| NCT01227434 A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma | Glioblastoma, Gliosarcoma | P2 | Terminated | 23 | Open-label | PD 0332991 (pre-surgery), PD 0332991 |
| NCT03407430 Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain | Breast Cancer, Lymphoma | P2 | Terminated | 11 | RCT, Double-blind | Pregabalin, Placebo |
| NCT00676429 Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders | Conduct Disorder, Oppositional Defiant Disorder | P2 | Completed | 51 | RCT, Double-blind | Ziprasidone Hydrochloride, Placebo |
| NCT00269672 Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Elderly Subjects | Vaccines, Pneumococcal Conjugate Vaccine | P2 | Completed | 915 | RCT, Open-label | 13-valent Pneumococcal Conjugate Vaccine |
| NCT00835900 An Alternative Dosing Schedule of Varenicline for Smoking Cessation | Smoking Cessation | P2 | Completed | 60 | RCT, Double-blind | varenicline, placebo |
| NCT00707239 Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia | Pneumonia, Bacterial | P2 | Terminated | 108 | RCT, Double-blind | tigecycline, tigecycline, imipenem/cilastatin |
| NCT06279195 Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment | Pelvic Pain | P2 | Withdrawn | — | Open-label | Relugolix (40 mg) /estradiol (1 mg)/norethisterone acetate (0.5 mg) oral tablet |
| NCT02040857 Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer | Breast Cancer | P2 | Completed | 162 | Open-label | Palbociclib, Aromatase Inhibitor |
| NCT00387660 Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer | Lung Cancer | P2 | Completed | 80 | Open-label | carboplatin, irinotecan |
| NCT01212718 Response Prediction in Metastasized Colorectal Cancer Using Intratumoral Thymidylate Synthase | Colorectal Cancer, Non Resectable Metastasis | P2 | Completed | 168 | RCT, Double-blind | FUFA, systemic chemotherapy |
| NCT00163085 The Effects of an NR2B NMDA Antagonist, CP-101,606, in Patients With Parkinson's Disease | Parkinson's Disease | P2 | Completed | 12 | RCT, Double-blind | NR2B NMDA Antagonist CP-101,606 (traxoprodil) |
| NCT01038297 Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty | Scar Prevention | P2 | Completed | 30 | RCT, Double-blind | EXC 001, Placebo |
| NCT00919035 Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients | Prostate Cancer | P2 | Completed | 21 | Open-label | torisel |
| NCT00662025 Study Of Sunitinib With Capecitabine In Breast Cancer | Advanced/Metastatic Breast Cancer | P2 | Completed | 63 | Open-label | Capecitabine, Sunitinib |
| NCT00031278 Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer | Carcinoma, Metastatic Breast | P1P2 | Completed | 12 | Open-label | CPG 7909, Herceptin®, CPG 7909, Herceptin®, CPG 7909, Herceptin®, CPG 7909, Herceptin® |
| NCT00355576 Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis | Amyotrophic Lateral Sclerosis | P2 | Completed | 86 | RCT, Double-blind | Celecoxib, Creatine, Minocycline |
| NCT02215252 A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN) | Diabetic Neuropathy, Painful | P2 | Completed | 141 | RCT, Double-blind | PF-05089771 150 mg, Matched placebo for PF-05089771 150 mg and pregabalin 300 mg, Pregabalin 300 mg, PF-05089771 150 mg + Pregabalin 300 mg |
| NCT02205476 A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study | Hypertrophic Scars Resulting From Prior Breast Scar Revision Surgery | P2 | Terminated | 10 | Open-label | PF-06473871, PF-06473871 |
| NCT00353808 A Trial Assessing The Long Term Safety And Tolerability Of [S,S]-Reboxetine In Patients With Post-Shingles Pain. | Pain | P2 | Terminated | 112 | Open-label | [S,S]-Reboxetine |
| NCT00949325 Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma | Sarcoma | P1P2 | Completed | 24 | Open-label | temsirolimus plus liposomal doxorubicin |
| NCT00614705 PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia | Neuralgia, Postherpetic | P2 | Completed | 80 | RCT, Double-blind | PH-797804, Placebo |
| NCT00143091 Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder | Depressive Disorder, Major | P2 | Terminated | 200 | RCT, Double-blind | CP-316,311, Placebo, Sertraline |
| NCT01592240 Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin | Hypercholesterolemia | P2 | Completed | 354 | RCT, Double-blind | PBO, 200mg PF-04950615 (RN316), 300mg PF-04950615 (RN316), PBO, PF-04950615, PF-04950615, PF-04950615 |
| NCT00510718 A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer | Prostate Cancer, Hormone Refractory Prostate Cancer | P1 | Completed | 140 | Open-label | MDV3100 |
| NCT01254396 Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Given With Or Without Food. | Erectile Dysfunction | P1 | Completed | 12 | RCT, Open-label | Sildenafil, Sildenafil |
| NCT00581789 Erlotinib and Sunitinib in NSCLC | Non Small Cell Lung Cancer | P1 | Completed | 11 | Open-label | erlotinib, sunitinib |
| NCT05652660 A Study to Understand the Effect of a Study Medicine Called ARV-471 on Rosuvastatin in Healthy Adults | Healthy | P1 | Completed | 12 | Open-label | ARV-471, Rosuvastatin |
| NCT06005688 A Study to Understand the Effects of Carbamazepine on How Vepdegestrant is Processed in Healthy Participants | Healthy Participants | P1 | Completed | 12 | Open-label | Vepdegestrant, Carbamazepine |
| NCT01256151 Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet | Anxiety Disorder | P1 | Completed | 28 | RCT, Open-label | Alprazolam tablet, Alprazolam sublingual |
| NCT00987779 Bioequivalence Study Of Gabapentin Between Tablet And Liquid Formulation And The Food Effect Study Of Liquid Formulation | Healthy | P1 | Completed | 26 | RCT, Open-label | Gabapentin, Gabapentin |
| NCT01046162 A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting Conditions | Healthy | P1 | Withdrawn | — | RCT, Open-label | Alprazolam, Alprazolam |
| NCT01285505 Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation | Healthy | P1 | Withdrawn | — | RCT, Open-label | alprazolam commercial sublingual formulation, alprazolam test sublingual tablet |
| NCT06466187 A Study of SGN-MesoC2 in Advanced Solid Tumors | Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms | P1 | Terminated | 19 | Open-label | PF-08052666 |
| NCT00800592 Sildenafil IV Bolus Study | Hypertension, Pulmonary | P1 | Completed | 12 | Open-label | sildenafil |
| NCT01330472 An Bioequivalence Study Of Xanax Extended Release Tablets From Two Different Manufacturing Sites | Healthy Subjects | P1 | Completed | 16 | RCT, Open-label | Xanax XR tablets 3 mg (sourced from Caugus), Xanax XR tablets 3 mg (sourced from Barceloneta) |
| NCT06120504 A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers | Lymphoma, T-Cell, Cutaneous, Hodgkin Disease | P1 | Terminated | 22 | Open-label | PF-08046045 |
| NCT00739999 8-Week PK/PD Atorvastatin Study In Children And Adolescents With Heterozygous Familial Hypercholesterolemia | Pediatric Heterozygous Hypercholesterolemia | P1 | Completed | 39 | Open-label | Atorvastatin, Atorvastatin |
| NCT04134884 Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer | Metastatic Breast Cancer, Triple Negative Breast Cancer | P1 | Completed | 34 | Open-label | Talazoparib, ASTX727 |
| NCT05930925 A Study to Understand How the Study Medicine Called ARV-471 is Processed in Healthy Adults | Healthy | P1 | Completed | 12 | RCT, Open-label | [phenyl-14C]ARV-471, [oxoisoindolin-14C]ARV-471 |
| NCT01389609 Bioequivalence Study of Doxazosin 4 Mg Orally-Disintegrating Tablet With Or Without Water To Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted Condition | Hypertension | P1 | Completed | 24 | RCT, Open-label | Doxazosin 4 mg Japanese marketed IR tablet, Doxazosin 4 mg ODT with water, Doxazosin 4 mg ODT without water |
| NCT00925106 Pharmacokinetics Of Celecoxib Test Formulations | Healthy Volunteers | P1 | Completed | 16 | RCT, Open-label | Celebrex capsule, Test formulation D1, Test formulation D2, Test formulation D3 |
| NCT06254495 A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers | Hodgkin Disease, Lymphoma, T-Cell, Peripheral | P1 | Terminated | 58 | Open-label | PF-08046044/SGN-35C |
| NCT00638742 A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost. | Glaucoma, Ocular Hypertension | P1 | Completed | 47 | Open-label | latanoprost |
| NCT00813241 A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy Volunteers | Healthy Volunteers | P1 | Completed | 16 | RCT, Open-label | celecoxib reference formulation, celecoxib test formulation A1, celecoxib test formulation B2, celecoxib test formulation C1 |
| NCT02637193 A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects | Healthy Subjects | P1 | Completed | 54 | RCT, Double-blind | Venlafaxine, Moxifloxacin, Drug - placebo |
| NCT01235195 A Study Comparing the Drug Exposure in Humans After Administration of a 50 mg Tablet of Sertraline Hydrochloride as Compared to a 50 mg Capsule of Sertraline Hydrochloride Under Fasted (Nonfed) Conditions | Healthy | P1 | Completed | 30 | RCT, Open-label | sertraline hydrochloride, sertraline hydrochloride |
| NCT06275841 A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine Vepdegestrant | Healthy | P1 | Completed | 12 | Open-label | vepdegestrant, esomeprazole |
| NCT01004614 Bioequivalence Study For 5 Mg Amlodipine Orally-Disintegrating Tablet | Healthy | P1 | Completed | 48 | RCT, Open-label | Amlodipine, Amlodipine, Amlodipine, Amlodipine |
| NCT01027117 A Relative Bioavailability Study of Revatio for the Crushed Tablets, Extemporaneously Prepared Formulation, and the Intact Tablets at 20 mg Dose in Healthy Volunteers | Healthy | P1 | Completed | 18 | RCT, Open-label | Revatio, Revatio, Revatio |
| NCT00990223 Effects Of Eplerenone On Serum Aldesterone And Plasma Renin Activity | Healthy Volunteers | P1 | Completed | 20 | RCT, Double-blind | Eplerenone or Placebo |
| NCT01737203 Bioequivalence Study For Orally-Disintegrating Tablet Of Sildenafil | Healthy | P1 | Completed | 53 | RCT, Open-label | Viagra, sildenafil ODT, sildenafil ODT |
| NCT01565928 Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer | Prostate Cancer | P1 | Completed | 23 | Open-label | MDV3100 |
| NCT02997176 An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800) | Advanced Solid Tumors | P1 | Completed | 38 | Open-label | Talazoparib |
| NCT02207504 Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer | Castration-resistant Prostate Cancer | P1 | Completed | 24 | Open-label | Crizotinib, Enzalutamide |
| NCT00950404 Bioavailability of 3 Sildenafil Oral Disintegrating Tablet Formulations Compared to the Standard Oral Tablet | Healthy Volunteers | P1 | Completed | 16 | RCT, Open-label | Viagra 50 mg tablet, Formulation B ODT tablet 50 mg, Formulation C ODT tablet 50 mg, Formulation D ODT tablet 50 mg |
| NCT01443169 A 5-treatment, Study in Healthy Volunteers to Assess The Safety, Tolerability, and Pharmacokinetics of Four Controlled Release (CR) Pregabalin Tablet Formulations and the Immediate Release (IR) Formulation Administered Fasted | Healthy | P1 | Completed | 16 | RCT, Open-label | Sequence 1 - Treatment A: Controlled Release Pregabalin, Sequence 1 - Treatment B: Controlled Release Pregabalin, Sequence 1 - Treatment C:Controlled Release Pregabalin, Sequence 1 - Treatment D: Controlled Release Pregabalin, Sequence 1 - Treatment E: Immediate Release Pregabalin, Sequence 2 - Treatment B: Controlled Release Pregabalin, Sequence 2 - Treatment D: Controlled Release Pregabalin, Sequence 2 - Treatment A: Controlled Release Pregabalin, Sequence 2 - Treatment C: Controlled Release Pregabalin, Sequence 2 - Treatment E: Immediate Release Pregabalin, Sequence 3 - Treatment C: Controlled Release Pregabalin, Sequence 3 - Treatment A: Controlled Release Pregabalin, Sequence 3 - Treatment D: Controlled Release Pregabalin, Sequence 3 - Treatment B: Controlled Release Pregabalin, Sequence 3 - Treatment E: Immediate Release Pregabalin, Sequence 4 - Treatment D: Controlled Release Pregabalin, Sequence 4 - Treatment C: Controlled Release Pregabalin, Sequence 4 - Treatment B: Controlled Release Pregabalin, Sequence 4 - Treatment A: Controlled Release Pregabalin, Sequence 4 - Treatment E: Immediate Release Pregabalin |
| NCT00827034 A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects | Alzheimer's Disease, Huntington's Disease | P1 | Completed | 14 | RCT, Open-label | Warfarin, Dimebon, Warfarin |
| NCT01291524 Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted At Bedtime Or Immediately Following A 400-500 or 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers | Healthy | P1 | Completed | 24 | RCT, Open-label | Pregabalin controlled release, 330 mg, 400 to 500 calorie, Pregabalin controlled release, 330 mg, 600- 750 calorie, Pregabalin controlled release, 330 mg, bedtime, Pregabalin immediate release, 300 mg |
| NCT01342198 An Investigation of the Effects of Erythromycin on the Pharmacokinetics of the Pregabalin Controlled Release Tablet | Healthy | P1 | Completed | 18 | RCT, Open-label | Pregabalin controlled release, 330 mg, Pregabalin controlled release, 330 mg, erythromycin |
| NCT04391868 A Bioequivalence Study of Sildenafil Citrate Orally-Disintegrating Film Dosage Form | Healthy | P1 | Withdrawn | — | RCT, Open-label | Viagra Tablet, Sildenafil Citrate ODF, Sildenafil Citrate ODF |
| NCT01177293 Bioavailability Study Comparing 10 mg Amlodipine Besylate Orally Disintegrating Tablets (ODT) And 10 mg Amlodipine Besylate Capsules | Healthy Volunteers | P1 | Completed | 14 | RCT, Open-label | Amlodipine - reference, Amlodipine ODT - test |
| NCT01008527 Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100 | Melanoma | P1 | Completed | 22 | Open-label | CP 870,893, Peptides, Oncovir poly IC:LC |
| NCT01423123 Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer | Breast Cancer | P1 | Completed | 21 | Open-label | Paclitaxel, trastuzumab, Neratinib |
| NCT00760474 An fMRI Study Of Brain Response In Patients With Fibromyalgia | Fibromyalgia | P1 | Completed | 27 | RCT, Double-blind | Pregabalin, then placebo, Placebo, then pregabalin |
| NCT01355068 A Study to Assess if Epanutin Infatabs 50 mg From Germany Are Similar to Dilantin Infatabs 50 mg From Australia | Healthy | P1 | Completed | 26 | RCT, Open-label | Epanutin Infatabs (Phenytoin), Dilantin Infatabs (Phenytoin) |
| NCT00758004 Bioequivalence Study Of Pediatric Appropriate Formulation | Hypercholesterolemia | P1 | Completed | 76 | RCT, Open-label | Atorvastatin, Atorvastatin pediatric appropriate formulation |
| NCT00877955 Bioequivalence Of A Test Alprazolam Sublingual Formulation Compared To A Commercial Sublingual Formulation | Healthy | P1 | Withdrawn | — | RCT, Open-label | alprazolam sublingual tablet commercial, alprazolam sublingual tablet test |
| NCT00866463 A Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects | Erectile Dysfunction | P1 | Completed | 18 | RCT, Open-label | Sildenafil, Sildenafil, Sildenafil |
| NCT00975481 A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users | Alzheimer's Disease, Huntington's Disease | P1 | Completed | 36 | RCT, Double-blind | dimebon, dimebon, dimebon, placebo, alprazolam, alprazolam |
| NCT00821444 Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules | Healthy | P1 | Completed | 11 | RCT, Open-label | ziprasidone, B16 Fasted, B16 Fed |
| NCT00795938 Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects. | Erectile Dysfunction | P1 | Completed | 18 | RCT, Open-label | Sildenafil, Sildenafil, Sildenafil |
| NCT01202422 An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule | Healthy | P1 | Completed | 24 | RCT, Open-label | Pregabalin controlled release, 165 mg, Pregabalin controlled release, 330 mg, Pregabalin immediate release, 150 mg |
| NCT01693445 S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer | Gastrointestinal Neoplasms | P1 | Completed | 22 | Open-label | OIS (Oxaliplatin, Irinotecan, S-1) |
| NCT00990613 A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin | Alzheimer's Disease, Huntington's Disease | P1 | Completed | 19 | RCT, Double-blind | Dimebon IR, Dimebon Transdermal, Dimebon Transdermal, Dimebon IR, Dimebon Transdermal |
| NCT01597193 Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer | Breast Cancer | P1 | Completed | 101 | Open-label | enzalutamide, anastrozole, exemestane, fulvestrant, enzalutamide, exemestane |
| NCT00831532 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function | Hepatic Failure | P1 | Completed | 23 | Open-label | Dimebon, Dimebon, Dimebon, Dimebon |
| NCT00720148 A Phase I Trial of Bortezomib and Sunitinib | Solid Tumors | P1 | Completed | 30 | Open-label | Sunitinib and Bortezomib |
| NCT01257529 An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following A Low, Medium, And High-Fat Evening Meal As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers | Healthy | P1 | Completed | 28 | RCT, Open-label | Pregabalin controlled release, 330 mg, low-fat, Pregabalin controlled release, 330 mg, medium-fat, Pregabalin controlled release, 330 mg, high-fat, Pregabalin immediate release, 300 mg |
| NCT00907322 A Phase 1 Trial To Assess The Safety And Pharmacokinetics Of Single, Ascending, Oral Doses Of Dimebon In Healthy Adults | Healthy Volunteers | P1 | Completed | 12 | RCT, Double-blind | Dimebon, Dimebon, Dimebon, Dimebon |
| NCT04176367 An Bioequivalence Study Comparing Nicergoline 10 mg Tablet Manufactured in China With Nicergoline 10 mg Tablet Manufactured in Italy Under Fasted and Fed Conditions in Healthy Chinese Participants | Pharmacokinetics | P1 | Completed | 40 | RCT, Open-label | Nicergoline from China, Nicergoline from Italy |
| NCT00481728 Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate. | Overactive Bladder | P1 | Completed | 28 | RCT, Double-blind | Tolterodine |
| NCT01286987 Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors | Advanced or Recurrent Solid Tumors, Breast Neoplasms | P1 | Completed | 113 | Open-label | Talazoparib |
| NCT00931073 A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers | Alzheimer's Disease, Huntington's Disease | P1 | Completed | 24 | Open-label | Dimebon alone, Dimebon + Ketoconazole, Dimebon + Omeprazole |
| NCT04703920 Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer | Metastatic Breast Cancer, Metastatic Castration-resistant Prostate Cancer | P1 | Completed | 26 | Open-label | Talazoparib, Belinostat |
| NCT02651623 Study to Evaluate The Effect Of Sertraline on the Cardiac Repolarization in Healthy Subjects | Healthy | P1 | Completed | 54 | RCT, Double-blind | Sertraline, Moxifloxacin, Drug - Placebo |
| NCT00860119 Bioequivalence of Alprazolam Sublingual vs Oral Tablets | Healthy | P1 | Completed | 23 | RCT, Open-label | alprazolam sublingual tablet, alprazolam oral tablet |
| NCT00904748 A Relative Bioavailability Study Between Two Formulations Of Sildenafil Citrate | Erectile Dysfunction | P1 | Completed | 47 | RCT, Open-label | sildenafil citrate 100 mg CT, sildenafil citrate 100 mg CT, Viagra® |
| NCT00777517 Bioequivalence Study On Pediatric Appropriate Formulation | Hypercholesterolemia | P1 | Completed | 76 | RCT, Open-label | Lipitor, Atorvastatin pediatric formulation |
| NCT03502681 A Study Combining Eribulin Mesylate With Avelumab in Cisplatin Ineligible Metastatic Urothelial Cell Cancer Patients | Metastatic Urothelial Cell Cancer | P1 | Terminated | 6 | Open-label | Eribulin Mesylate, Avelumab |
| NCT05571839 A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors | Cutaneous Melanoma, Non-small Cell Lung Cancer | P1 | Terminated | 41 | Open-label | PF-08046049 |
| NCT00788047 A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan | Huntington Disease, Alzheimer Disease | P1 | Completed | 14 | RCT, Open-label | Dextromethorphan, Dimebon + Dextromethorphan |
| NCT00871806 Pharmacokinetics of Two Eletriptan Oral Formulations Given With and Without Water and the Commercial Tablet Formulation Given With Water | Healthy Volunteers | P1 | Completed | 20 | RCT, Open-label | Commercial tablet with water, ODT #1 without water, ODT #2 without water, ODT #1 with water, ODT #2 with water |
| NCT00824590 A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function | Alzheimer's Disease, Huntington's Disease | P1 | Completed | 20 | Open-label | Dimebon, Dimebon |
| NCT00998036 Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors | Triple Negative Breast Cancer | P1 | Completed | 9 | Open-label | Temsirolimus, Cisplatin, Erlotinib |
| NCT02725112 Bioavailability Study of Pregabalin Extended Release Formulation With Various Release Rates in Healthy Volunteers | Healthy | P1 | Completed | 25 | RCT, Open-label | Pregabalin ER, Pregabalin ER, Pregabalin ER, Pregabalin ER, Pregabalin ER, Pregabalin ER |
| NCT05501769 ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer | Breast Cancer | P1 | Completed | 32 | Open-label | ARV-471 in combination with Everolimus |
| NCT06347861 A Study to Learn How Various Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood of Healthy Adults | Healthy | P1 | Completed | 52 | RCT, Open-label | single dose of vepdegestrant as tablet formulation (Treatment A), single dose of vepdegestrant as tablet formulation (Treatment B), single dose of vepdegestrant as tablet formulation (Treatment C) |
| NCT01111188 Trial of PD 0332991 Plus Bortezomib in Patients With Relapsed Mantle Cell Lymphoma | Mantle Cell Lymphoma | P1 | Terminated | 20 | Open-label | PD 0332991, bortezomib |
| NCT04498520 Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer | Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | P1 | Withdrawn | — | Open-label | Abexinostat Tosylate, Fulvestrant, Palbociclib |
| NCT00506805 Safety And Pharmacology Study Of SNX-5422 Mesylate In Subjects With Refractory Solid Tumor Malignancies | Cancer | P1 | Completed | 44 | Open-label | SNX-5422 |
| NCT05014139 A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) | Urinary Bladder Neoplasms, Carcinoma in Situ | P1 | Terminated | 37 | Open-label | Enfortumab vedotin |
| NCT01257516 An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy Volunteers | Healthy | P1 | Completed | 18 | RCT, Open-label | Pregabalin immediate release, 300 mg, Pregabalin controlled release, 330 mg |
| NCT06645938 A Study to Learn How Different Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood in Healthy Adults | Healthy | P1 | Completed | 12 | RCT, Open-label | single dose of vepdegestrant as tablet formulation (Treatment A), single dose of vepdegestrant as tablet formulation (Treatment B) |
| NCT01656798 Food Effect Study For New Formulation | Healthy | P1 | Completed | 12 | RCT, Open-label | sildenafil citrate, sildenafil citrate |
| NCT06256510 A Study to Learn If the Study Medicine Called Vepdegestrant Changes How the Body Processes the Other Study Medicine Called Midazolam | Healthy Participants | P1 | Completed | 15 | Open-label | Midazolam, Vepdegestrant |
| NCT01247805 A Pivotal Bioequivalence Study Between The Sildenafil Powder For Oral Suspension (10 Mg/Ml) And The Sildenafil 10 Mg Immediate Release (IR) Tablet Relative To The Revatio 20 Mg IR Tablet In Healthy Volunteers Under Fasting Conditions | Pulmonary Arterial Hypertention | P1 | Completed | 42 | RCT, Open-label | sildenafil citrate, Sildenafil citrate, sildenafil citrate |
| NCT01027689 Bioequivalence of a New Sublingual and a Reference Alprazolam Immediate Release Tablet Formulation | Healthy | P1 | Withdrawn | — | RCT, Open-label | alprazolam commercial immediate release oral tablet, alprazolam test sublingual tablet |
| NCT01521767 Pharmacokinetics and Relative Bioavailability Study | Urinary Bladder, Overactive | P1 | Completed | 16 | RCT, Open-label | tolterodine tartrate, tolterodine tartrate, tolterodine tartrate, tolterodine tartrate, tolterodine tartrate |
| NCT01270815 An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following Various Sized Lunches As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers | Healthy | P1 | Completed | 28 | RCT, Open-label | Pregabalin controlled release, 330 mg, 400 to 500 calories, Pregabalin controlled release, 330 mg, 600 to 750 calories, Pregabalin controlled release, 330 mg, 800 to 1000 calories, Pregabalin immediate release, 300 mg |
| NCT00831506 Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects | Alzheimer Disease, Huntington Disease | P1 | Completed | 12 | RCT, Double-blind | digoxin, digoxin, dimebon |
| NCT01321671 Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted In The Evening or Immediately Following A 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers | Healthy | P1 | Completed | 24 | RCT, Open-label | Pregabalin controlled release, 330 mg, 600- 750 calorie, Pregabalin controlled release, 330 mg, fasted, Pregabalin immediate release, 300 mg |
| NCT03070548 A Study of Talazoparib in Patients With Advanced Solid Tumors | Advanced Solid Tumors | P1 | Completed | 6 | Open-label | Talazoparib |
| NCT00825084 A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects | Alzheimer's Disease, Huntington's Disease | P1 | Completed | 45 | RCT, Double-blind | Dimebon, Dimebon, Dimebon, Dimebon |
| NCT01399840 Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies | Acute Myeloid Leukemia, Myelodysplastic Syndrome | P1 | Completed | 33 | Open-label | BMN 673 |
| NCT01989143 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Intravenous and Multiple Subcutaneous and Intravenous Doses of PF-06480605 in Healthy Subjects. | Healthy | P1 | Completed | 92 | RCT, Double-blind | PF-06480605, Placebo, PF-06480605, Placebo, PF-06480605, Placebo |
| NCT06646042 A Study to Learn If the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine Ibuzatrelvir in Healthy Adults | Healthy | P1 | Completed | 12 | RCT, Open-label | ibuzatrelvir, carbamazepine ER |
| NCT01065662 AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies | Endometrial Cancer, Ovarian Cancer | P1 | Completed | 11 | Open-label | temsirolimus, cediranib |
| NCT00440427 Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR) | Depressive Disorder, Major | P1 | Completed | 12 | RCT, Open-label | Desvenlafaxine Sustained Release (DVS SR) |
| NCT04604496 STUDY OF PF-06882961 IN PARTICIPANTS WITH AND WITHOUT VARYING DEGREES OF HEPATIC IMPAIREMENT | Hepatic Impairment, Healthy Volunteers | P1 | Completed | 24 | Single-blind | PF-06882961 20MG |
| NCT04171141 Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors. | Gastrointestinal Tumors, Colorectal Adenocarcinomas | P1 | Terminated | 79 | Open-label | PF-07062119, Anti-PD1, Anti-VEGF |
| NCT01044537 A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus | Type 2 Diabetes Mellitus | P1 | Completed | 50 | RCT, Double-blind | Placebo, PF-04937319 |
| NCT00788294 Measure Exposure Of Tanezumab In Healthy Volunteers When Administering The Drug Subcutaneously | Healthy Volunteers | P1 | Completed | 76 | Open-label | tanezumab, tanezumab, tanezumab, tanezumab |
| NCT02316756 A Single Ascending Dose Study To Evaluate Safety And Pharmacokinetics Of Compound PF-06648671 In Healthy Subjects | Healthy Subjects | P1 | Completed | 18 | RCT, Double-blind | PF-06648671, Placebo |
| NCT02537002 Single Dose Study of PF-05230907 in Healthy Japanese Subjects | Healthy | P1 | Completed | 17 | RCT, Double-blind | PF-05230907, PF-05230907, Placebo |
| NCT05386472 A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19 | COVID-19 | P1 | Terminated | 25 | Open-label | nirmatrelvir, ritonavir |
| NCT01092845 Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers | Healthy, Sleep | P1 | Completed | 30 | RCT, Double-blind | PF-04457845 / matched placebo, PF-04457845 / matched placebo |
| NCT02014272 A Bioequivalence Study Comparing A Fixed Dose Combination Formulation, Rin 150 And Individual Reference Drugs In Healthy Volunteers | Healthy Volunteers | P1 | Completed | 28 | RCT, Open-label | RIN 150, reference drugs |
| NCT04124653 A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PF-06842874 in Healthy Participants | Healthy Participants | P1 | Completed | 44 | RCT, Double-blind | PF-06842874, Placebo, Relative Bioavailability |
| NCT02038777 A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies | Acute Myeloid Leukemia | P1 | Completed | 48 | Open-label | PF-04449913, PF-04449913, Low dose ARA-C (LDAC), PF-04449913, Daunorubicin, Cytarabine, PF-04449913, Azacitidine, PF-04449913, LDAC |
| NCT03343054 A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors | Neoplasms, Breast Neoplasms | P1 | Completed | 28 | Open-label | talazoparib |
| NCT03448172 Single-dose Study of [14C]PF-05221304 Metabolism and Excretion in Healthy Adult Male Subjects | Healthy | P1 | Completed | 6 | Open-label | [14C]PF-05221304 |
| NCT04621227 Study To Evaluate The Effect Of Two Steady State Doses of PF 06882961 On Rosuvastatin And Midazolam Pharmacokinetics In Otherwise Healthy Adult Participants With Obesity | Obesity | P1 | Completed | 16 | Open-label | PF-06882961, Rosuvastatin, Midazolam |
| NCT01184001 A Study To Evaluate The Effect Of Food On How Tasocitinib (CP-690,550) Is Absorbed And Moves Through The Body Following Oral Administration Of Tasocitinib (CP-690,550) Tablets To Healthy Subjects | Rheumatoid Arthritis | P1 | Completed | 16 | RCT, Open-label | Treatment A, Treatment B, Treatment B, Treatment A |
| NCT02097329 Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food | Healthy | P1 | Completed | 27 | Open-label | palbociclib commercial free base, famotidine, rabeprazole, palbociclib commercial free base, antacid, antacid |
| NCT00195312 Study Evaluating Vaccine in Adults With HIV | HIV Infections | P1 | Terminated | 91 | RCT, Double-blind | HIV-1 gag DNA (formulated with bupivacaine), IL-15 DNA (formulated with bupivacaine), IL-12 DNA (formulated with bupivacaine), Sodium chloride injection USP (0.9%) |
| NCT00479219 Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients | Alzheimer Disease | P1 | Completed | 17 | RCT, Double-blind | GSI-953 |
| NCT00759564 A Study To Investigate The Pharmacokinetics, Safety And Tolerability Of An Intravenous And Oral Form Of A Compound In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function | Pneumonia | P1 | Completed | 29 | Open-label | CP-70,429 and PF-03709270 |
| NCT01314898 A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy Volunteers | Healthy Volunteers | P1 | Completed | 12 | RCT, Double-blind | 3 mg PF-03882845, 10 mg PF-03882845, 30 mg PF-03882845, 100 mg PF-03882845, Spironolactone |
| NCT01286454 This Is A Study Of Bioavailability And Food Effect For Fesoterodine. | Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency | P1 | Completed | 20 | RCT, Open-label | fesoterodine, fesoterodine, fesoterodine, fesoterodine, fesoterodine, fesoterodine |
| NCT01597895 Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy Subjects | Healthy | P1 | Completed | 14 | Open-label | Maraviroc, Maraviroc + Boceprevir, Maraviroc + Telaprevir |
| NCT07731100 A Study to Learn About How Food Affects the Uptake of Study Medicine Prifetrastat Into the Blood in Healthy Adults | Healthy Adults | P1 | Not Yet Recruiting | 12 | RCT, Open-label | Prifetrastat |
| NCT01250730 A Study In Japanese Healthy Male Volunteers To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-02341066 | Healthy | P1 | Completed | 18 | Open-label | PF-02341066, PF-02341066, PF-02341066 |
| NCT01100060 A Phase 1 Study To Estimate The Relative Bioavailability Of Co-Administered Formulations Of Azithromycin Microsphere And Chloroquine Test Formulation Compared With Co-Administered Immediate Release Individual Azithromycin And Chloroquine Tablets In Healthy Adult Subjects | Malaria Prophylaxis | P1 | Completed | 40 | RCT, Open-label | azithromycin (AZ) microsphere, test chloroquine (CQ) formulation, azithromycin (AZ), chloroquine (CQ) |
| NCT00136968 Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy | Fungal Infection | P1 | Completed | 12 | Open-label | Voriconazole |
| NCT07015918 A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men | Healthy Male Volunteers | P1 | Completed | 8 | Open-label | [14C] PF-07976016, PF-07976016, [14C] PF-07976016 |
| NCT00038922 Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis | Ulcerative Colitis, Inflammatory Bowel Disease | P1 | Terminated | — | — | rhIL-11 |
| NCT00781794 Study Evaluating The Effects Of Single Oral Doses Of NSA-789 On Auditory P50 Suppression In Schizophrenic Patients | Schizophrenia | P1 | Withdrawn | — | RCT, Double-blind | NSA-789 at 2 different doses |
| NCT03793439 Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis | Sarcoidosis, Pulmonary, Sarcoidosis Lung | P1 | Completed | 5 | Open-label | Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial, Corticosteroid, Tofacitinib 5mg [Xeljanz] 1 year open-label extension |
| NCT05489328 Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age | Pneumococcal Disease | P1 | Completed | 394 | RCT, Open-label | 13vPnC, PCV15 |
| NCT01199029 Single Dose Study Of PF-04308515 And Prednisone On Carbohydrate | Healthy | P1 | Completed | 18 | RCT, Open-label | PF-04308515, PF-04308515, Prednisone, PF-04308515, PF-04308515, Prednisone, Prednisone |
| NCT01664065 A Study to Assess the Pharmacokinetics of Ceftaroline in End Stage Renal Disease Patients and Matched Healthy Subjects | Renal Disease | P1 | Completed | 15 | Open-label | 200 mg Ceftaroline fosamil, 600 mg Ceftaroline fosamil |
| NCT03469336 Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis | Psoriasis | P1 | Completed | 18 | RCT, Open-label | PF-06763809, Calcipotriene/calcipotriol, Betamethasone |
| NCT00593008 Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer | Pancreatic Adenocarcinoma | P1 | Terminated | 5 | Open-label | Temsirolimus, Gemcitabine |
| NCT00814736 A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031 | Prostatic Hyperplasia, Urinary Bladder, Overactive | P1 | Completed | 22 | RCT, Double-blind | UK369,003, sildenafil, sildenafil matching placebo |
| NCT00472927 Bioequivalence Study of 3 New Formulations of Premarin/MPA Compared With Premarin/MPA (Prempro) | Postmenopause | P1 | Completed | — | RCT, Open-label | Premarin/MPA 0.45 mg/1.5 mg |
| NCT02725437 Clostridium Difficile Vaccine Safety, Tolerability, and Immunogenicity Study in Japanese Adults | Clostridium Difficile Associated Disease | P1 | Completed | 100 | RCT, Double-blind | Clostridium difficile Vaccine, Placebo |
| NCT00291577 Study Of SU011248 In Combination With Docetaxel In Patients With Metastatic Breast Cancer | Breast Neoplasms | P1 | Completed | 22 | Open-label | Sunitinib (Sutent), Taxotere |
| NCT01707394 Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder | Thromboembolism | P1 | Completed | 49 | Open-label | Apixaban |
| NCT06675188 A Study to Learn More About the Study Medicine PF-07275315 in Healthy Chinese Adult Participants | Healthy | P1 | Completed | 13 | RCT, Double-blind | PF-07275315 |
| NCT00340327 Study Evaluating IMA-638 in Healthy Japanese | Healthy | P1 | Completed | — | RCT, Double-blind | IMA-638 |
| NCT01934569 Drug-Drug Interaction Study With PF-05089771 | Healthy | P1 | Completed | 17 | Open-label | Pravastatin, midazolam, losartan, omeprazole, caffeine and PF-05089771 |
| NCT03210961 A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis | Plaque Psoriasis | P1 | Completed | 109 | RCT, Double-blind | PF-06826647 tablet, PF-06826647 oral suspension |
| NCT02430545 Understanding The Effect Of A Strong CYP3A4 Inducer On Glasdegib Pharmacokinetics | Healthy Volunteers | P1 | Completed | 12 | Open-label | Glasdegib, Rifampin |
| NCT02006277 A Study To Taste Three New Types Of Crizotinib Formulation In Comparison Of An Oral Solution And To Measure The Amount Of Crizotinib In The Body After These Formulations Are Orally Given, Relative To Capsule Formulation | Healthy | P1 | Completed | 21 | Open-label | Crizotinib prototype microsphere 0.529 mg/mg, crizotinib prototype microsphere 0.470 mg/mg, crizotinib prototype microsphere 0.420 mg/mg, crizotinib oral solution, crizotinib prototype microsphere 0.529 mg/mg, crizotinib prototype microsphere 0.470 mg/mg, crizotinib prototype microsphere 0.420 mg/mg, crizotinib capsule, crizotinib oral solution |
| NCT06705569 A Study to Compare Two Forms of Study Medicine Tafamidis in the Blood in Healthy Adults | Healthy | P1 | Completed | 22 | RCT, Open-label | Tafamidis 61 mg free acid tablet (Test), Tafamidis 61 mg free acid capsule (Reference) |
| NCT03230383 A Study To Assess The Safety, Tolerability, And Pharmacokinetics (PK) Of Multiple Doses Of PF-06865571 In Healthy, Including Overweight And Obese, Adult Subjects | Healthy Subjects | P1 | Completed | 60 | RCT, Double-blind | PF-06865571, PF-06865571, PF-06865571, PF-06865571, PF-06865571, PF-06865571, PF-06865571, Placebo |
| NCT00725582 Study Evaluating the Effect of IMA-026 on Allergen-Induced Late Asthma Response in Mild Asthma | Asthma | P1 | Completed | 24 | RCT, Double-blind | IMA-026 |
| NCT01003691 Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy | Age-Related Maculopathy, Age-Related Maculopathies | P1 | Completed | 24 | RCT, Double-blind | RN6G, Placebo |
| NCT00479440 Study Evaluating the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of SAM-315 in Healthy Adults | Alzheimer Disease | P1 | Completed | 56 | RCT, Double-blind | SAM-315 |
| NCT00909688 Study to Evaluate Whether BLI-489 Can be Safely Tolerated by Healthy Subjects Given Multiple Doses | Healthy | P1 | Completed | 16 | RCT, Double-blind | BLI-489, placebo |
| NCT01217918 Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects | Healthy | P1 | Completed | 30 | RCT, Double-blind | 1 mg, 5 mg, 10 mg |
| NCT01054300 Effects of Once and Twice Daily Dosing Regimen of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-040) | Diabetes Mellitus, Type 2, Adult | P1 | Completed | 52 | RCT, Double-blind | Ertugliflozin 2 mg single dose, Ertugliflozin 2 mg split into twice daily, Ertugliflozin 4 mg single dose, Ertugliflozin 4 mg split into twice daily, Placebo |
| NCT00596518 A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney Function | Renal Insufficiency, Chronic | P1 | Completed | 30 | Open-label | PF-00734200 |
| NCT05831124 A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to Adults | Pneumococcal Disease | P1 | Completed | 90 | RCT, Double-blind | Low dose of multivalent pneumococcal conjugate vaccine control, Standard dose multivalent pneumococcal conjugate vaccine control |
| NCT01244880 Effects Of PF-02545920 On Ketamine-Induced Abnormal Prefrontal Brain Response To Associative Learning In Healthy Subjects | Healthy | P1 | Terminated | 4 | RCT, Double-blind | PF-02545920, PF-02545920 |
| NCT02030483 Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma | Multiple Myeloma | P1 | Terminated | 9 | Open-label | Palbociclib, Dexamethasone, Lenalidomide |
| NCT03267836 Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma | Meningioma, Meningioma, Adult | P1 | Terminated | 9 | Open-label | Avelumab |
| NCT00447863 Study Evaluating the Bioequivalence of Levonorgestrel/Ethinyl Estradiol Combinations in Cycling Women | Contraception | P1 | Withdrawn | — | RCT, Open-label | Levonorgestrel/Ethinyl Estradiol |
| NCT00328432 A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy | Breast Cancer | P1 | Completed | 100 | RCT, Double-blind | celecoxib 400 mg bid |
| NCT00928551 Comparative Formulation Study of Vabicaserin | Healthy Subjects | P1 | Completed | 15 | RCT, Open-label | vabicaserin |
| NCT02170012 A Study In Healthy Elderly People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses Of PF-06743649 | Healthy Elderly | P1 | Terminated | 24 | RCT, Double-blind | PF-06743649, Placebo, PF-06743649, Placebo, PF-06743649, Placebo, PF-06743649, Placebo, PF-06743649, Placebo |
| NCT01706367 Evaluation of a 3-dose Vaccination Regimen With One of Three Ascending Dose Levels of Clostridium Difficile Vaccine With or Without Adjuvant in Healthy Adults Aged 50 to 85 Years | Clostridium Difficile Associated Disease | P1 | Completed | 192 | RCT, Single-blind | C. difficile vaccine, C. difficile vaccine +adjuvant, C. difficile vaccine, C. difficile vaccine +adjuvant, C. difficile vaccine, C. difficile vaccine +adjuvant |
| NCT04889157 A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PF-06882961 in Chinese Adults With Type 2 Diabetes Mellitus | Diabetes Mellitus, Type 2 | P1 | Completed | 20 | RCT, Double-blind | PF-06882961, Placebo |
| NCT00996346 Phase I/II Study of Irinotecan and Temsirolimus in Patients With Refractory Sarcomas | Sarcoma | P1 | Terminated | 17 | Open-label | Irinotecan&Temsirolimus:Arm1, Level 1, Irinotecan&Temsirolimus:Arm 1, Level 2, Irinotecan&Temsirolimus:Arm 2, Level 1 |
| NCT01002625 A Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers | Sleep, Healthy Volunteers | P1 | Terminated | 18 | RCT, Double-blind | PF-04457845 / matched placebo, PF-04457845 / matched placebo |
| NCT00906191 Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects | Alzheimer Disease | P1 | Completed | 6 | Open-label | SAM-531 |
| NCT00879983 An Open Label, Randomized, Crossover Study To Estimate The Pharmacokinetics And Evaluate The Safety Following A Single Dose Of Azithromycin 2g Extended-Release Powder For Oral Suspension With A 3-Day Dosing Regimen Of Azithromycin 500mg Tablet In Chinese Healthy Male Subjects | Healthy Volunteers | P1 | Completed | 24 | RCT, Open-label | azithromycin (Zithromax), azithromycin (Zithromax) |
| NCT01948986 Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009) | Renal Impairment, Type 2 Diabetes Mellitus | P1 | Completed | 36 | Open-label | Ertugliflozin |
| NCT05900154 A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age | RESPIRATORY SYNCYTIAL VIRUS (RSV) | P1 | Completed | 128 | RCT, Open-label | RSVpreF 120 µg, RSVpreF 60 µg |
| NCT00867282 A Study to Estimate the Time Course of PF-00241939 Concentration in the Blood Following Dosing by Oral Inhalation From Dry Powder Inhalers | Pharmacokinetics | P1 | Completed | 36 | RCT, Open-label | Treatment A, Treatment B |
| NCT00894660 A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects | Falciparum Malaria | P1 | Completed | 38 | Open-label | Amodiaquine (Test), Amodiaquine (Comparator) |
| NCT01011296 First In Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429 Administered Intravenously To Healthy Adult Volunteers | Healthy Volunteers | P1 | Completed | 24 | RCT, Double-blind | PF-04427429, PF-04427429, PF-04427429 |
| NCT00999817 A Pharmacokinetic (PK) Study Of PF-00299804 And Dextromethorphan In Healthy Volunteers | Healthy Volunteers | P1 | Completed | 14 | RCT, Open-label | reference [dextromethorphan], test [PF-00299804 + dextromethorphan] |
| NCT00369304 Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between CYP2C9 Inhibitor and Substrate | Healthy Subjects | P1 | Completed | — | RCT, Open-label | pharmacokinetic (how the body absorbs and eliminates) interaction |
| NCT00297687 Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults | Meningitis, Meningococcal | P1 | Completed | 108 | RCT, Double-blind | MnB rLP2086 |
| NCT00832806 Smoke-Free Living Study | Additional, Effective Methods to Stop Smoking | P1 | Completed | 100 | RCT, Open-label | Varenicline (Champix) |
| NCT05654181 A First-in-human Study of Single Doses of PF-07328948 Which is Given to Healthy Adult Participants | Healthy | P1 | Completed | 20 | RCT, Double-blind | PF-07328948, Placebo |
| NCT00918164 Evaluation Of The Relative Bioavailability Of PF-04457845 Tablet To Solution Formulation And Food Effect In Healthy Subjects | Healthy Volunteers | P1 | Completed | 12 | RCT, Open-label | PF-04457845 |
| NCT02262533 Phase 1 Drug Interaction Study of Apixaban and Atenolol in Healthy Subjects | N/A - Healthy Subjects | P1 | Completed | 15 | RCT, Open-label | Apixaban, Atenolol |
| NCT00815906 Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid Arthritis | Arthritis, Rheumatoid | P1 | Completed | 20 | Open-label | SBI-087, SBI-087, SBI-087, SBI-087 |
| NCT00729833 Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors | Advanced Cancer, Advanced Solid Tumors | P1 | Terminated | 45 | Open-label | CP-751,871, Sunitinib |
| NCT07009353 A Study to Learn How the Study Medicine Called [14C]PF-07054894 is Processed by the Body | Healthy | P1 | Completed | 10 | Single-blind | PF-07054894, PF-07054894 |
| NCT01005472 Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma | Metastatic Melanoma | P1 | Completed | 16 | Open-label | sunitinib malate, temozolomide |
| NCT02059330 A Study To Investigate Palbociclib (PD-0332991) Pharmacokinetics In Healthy Subjects Of Japanese Descent Relative To Healthy Non-Asian Subjects, And To Determine If Changes In Palbociclib Dose Result In Proportional Changes In Palbociclib Plasma Exposure In Japanese Subjects | Healthy | P1 | Completed | 27 | Open-label | Palbociclib 75mg, Palbociclib 125mg, Palbociclib 100mg, Palbociclib, Palbociclib 125mg |
| NCT04338711 A Study In Adult Healthy Volunteers To Asses Once Daily (QD) Dosing With The Selected Age-Appropriate Modified Release (MR) Formulations | Healthy | P1 | Completed | 23 | RCT, Open-label | tofacitinib modified release (MR) |
| NCT01522807 A Study Of Three PF-05190457 Formulations In Healthy Volunteers | Diabetes Mellitus, Type 2 | P1 | Completed | 16 | RCT, Double-blind | PF-05190457, PF-05190457, PF-05190457, PF-05190457, PF-05190457, PF-05190457, PF-05190457, PF-05190457 |
| NCT05061277 Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Recifercept in Healthy Chinese Participants | Healthy | P1 | Withdrawn | — | Open-label | Recifercept |
| NCT00800722 A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks. | Port Wine Stain | P1 | Completed | 21 | Open-label | Rapamycin Treatment of Port Wine Stain |
| NCT01272375 This Study Is To Estimate The Time Course Of Pf-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers | Healthy | P1 | Completed | 48 | RCT, Open-label | Treatment A, Treatment B, Treatment C, Treatment D, Treatment E, Treatment F, Treatment G |
| NCT01649336 A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer | Epithelial Ovarian Cancer, Fallopian Tube Cancer | P1 | Completed | 36 | Open-label | MEK162, MEK inhibitor; oral, Paclitaxel, mitotic inhibitor; intravenous |
| NCT01061411 Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery | Clear Cell Sarcoma of the Kidney, Recurrent Renal Cell Carcinoma | P1 | Completed | 16 | Open-label | Dalteparin, Sunitinib Malate |
| NCT05224609 A Study to Learn About the Study Medicine (Called Lorlatinib) in People With Liver Dysfunction | Moderate Hepatic Impairment, Severe Hepatic Impairment | P1 | Completed | 21 | Open-label | Lorlatinib |
| NCT07172321 A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults | Atopic Dermatitis | P1 | Completed | 12 | RCT, Open-label | PF-08049820 MR1, PF-08049820 MR2, PF-08049820 IR |
| NCT01396187 Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 Diabetes | Diabetes Mellitus, Type 2 | P1 | Completed | 50 | RCT, Double-blind | PF-05231023, PF-05231023, PF-05231023, PF-05231023 |
| NCT00645463 Effect of Diltiazem Administration on CP-945,598 Pharmacokinetics | Obesity | P1 | Completed | 28 | RCT, Open-label | CP-945,598, CP-945,598 |
| NCT00716521 Effect Of Treatment With Oral Zolpidem On Polysomnography And Actigraphy Measures In Healthy Volunteers | Methodology Study | P1 | Completed | 11 | RCT, Single-blind | placebo, zolpidem, zolpidem |
| NCT00832052 A Study to Evaluate Safety, Tolerability, Plasma Drug Levels, and Cognitive Response Following Multiple Doses of a Drug in Healthy Elderly Participants. | Healthy, Elderly | P1 | Completed | 32 | RCT, Double-blind | PF-04447943, PF-04447943, PF-04447943, PF-04447943, PF-04447943 |
| NCT04983264 A Study to Evaluate GBT021601-012 Single Dose and Multiple Dose in Participants With Sickle Cell Disease (SCD) | Sickle Cell Disease | P1 | Completed | 6 | Open-label | GBT021601 |
| NCT00886093 A Study To Evaluate Whether Food Affects The Plasma Drug Levels Of A 35 mg Single Dose Of PF-04447943 Taken Orally In Healthy Adult Participants | Healthy | P1 | Completed | 10 | RCT, Open-label | PF-04447943, PF-04447943 |
| NCT01129258 Multiple Dose Study of PF-04991532 in Patients With Type 2 Diabetes | Diabetes Mellitus, Diabetes Mellitus, Type 2 | P1 | Completed | 110 | RCT, Double-blind | PF-04991532, Placebo |
| NCT01653158 CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies | Advanced Non-Hematologic Malignancies | P1 | Completed | 46 | Open-label | CP-751,871, Docetaxel |
| NCT00784420 Drug Interaction Study Between Raltegravir And UK-453,061 | Healthy Volunteers | P1 | Completed | 18 | RCT, Open-label | UK-453,061, UK-453,061, Raltegravir, Raltegravir |
| NCT01064726 A Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response. | Allergic Rhinitis | P1 | Completed | 18 | RCT, Double-blind | Ibuprofen, Fluticasone propionate, Placebo |
| NCT02767089 The Dose Response of Prednisone on Biochemical and Clinical Makers in Adult Healthy Volunteers | Healthy Adults | P1 | Completed | 37 | RCT, Single-blind | Prednisone, Placebo |
| NCT01775189 A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and Snorted | Healthy | P1 | Completed | 45 | RCT, Double-blind | ALO-02 weight-matched placebo, crushed ALO-02 30 mg/3.6 mg, oxycodone weight-matched placebo, crushed oxycodone IR 30 mg |
| NCT00990015 A Phase 1 Single-Dose Escalation Study of PF-04308515 in Healthy Volunteers | Healthy Volunteers | P1 | Completed | 27 | RCT, Double-blind | PF-04308515, Placebo |
| NCT00147485 A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With Advanced Cancer | Neoplasms, Lymphoma, Non-Hodgkin | P1 | Terminated | 37 | Open-label | AG-024322 |
| NCT00397891 Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease | Alzheimer Disease | P1 | Completed | 80 | RCT, Double-blind | bapineuzumab, bapineuzumab, bapineuzumab |
| NCT01429740 A Study Of The Safety, Tolerability And Pharmacokinetics Of Single Doses Of PF-05180999 In Healthy Adults | Schizophrenia | P1 | Completed | 29 | RCT, Double-blind | PF-05180999, Placebo |
| NCT01055769 Bioequivalence Study Comparing Linezolid 600 Mg Oral Suspension With 600 Mg Tablet In Chinese Healthy Male Subjects | Healthy Volunteers | P1 | Completed | 20 | RCT, Open-label | Linezolid, Linezolid |
| NCT05434091 A First-In-Human Study of the Study Medicine, Called PF-07291177, in Healthy Adult Participants | Healthy Participants | P1 | Withdrawn | — | RCT, Double-blind | PF-07291177, Placebo |
| NCT05650333 A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Areata (AA) In Children 6 To Less Than 12 Years of Age | Alopecia Areata | P1 | Completed | 15 | Open-label | Ritlecitinib 20 mg |
| NCT06799533 A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors | Malignant Melanoma, Melanoma | P1 | Terminated | 11 | Open-label | PF-08046031 |
| NCT01034748 A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers | Carcinoma, Non-Small-Cell Lung | P1 | Completed | 6 | Open-label | [14C]PF00299804 |
| NCT00857571 A Four-Way Cross-Over Study To Compare The Plasma Concentrations Of PF-02413873 After Oral Administration Of Several Doses As Suspension And As Tablets. | Healthy | P1 | Terminated | 12 | RCT, Open-label | 150 mg Suspension, 30 mg Suspension, 400 mg Suspension, 5 mg Suspension, 750 mg Suspension, 150 mg Tablet, 30 mg Tablet, 400 mg Tablet, 5 mg Tablet, 750 mg Tablet |
| NCT02201511 A Healthy Volunteer Trial to Gain Information About the Blood Concentrations of PF-06412562 After Oral Administration of a Modified Release Formulation in Fasted and Fed Conditions | Healthy | P1 | Completed | 12 | RCT, Open-label | 3 mg PF-06412562 MR tablets_Fasted, 2 x 15 mg PF-06412562 MR tablets_Fasted, 2 x 15 mg PF-06412562 MR tablets_Fed, 10 mg PF-06412562 IR tablets |
| NCT04634565 PHARMACOKINETIC CHARACTERIZATION OF PF-06651600 IN CHINESE ADULT PARTICIPANTS | Healthy Participants | P1 | Completed | 9 | Open-label | PF-06651600 |
| NCT04535167 First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19. | Viral Disease | P1 | Completed | 26 | RCT, Double-blind | PF-07304814, Placebo |
| NCT00630435 Study Comparing 3 New Formulations of Premarin® 0.625 mg/MPA 2.5 mg With a Reference Formulation | Menopause | P1 | Completed | 76 | RCT, Open-label | Premarin®/MPA formulation A, Premarin®/MPA formulation B, Premarin®/MPA formulation C, Premarin®/MPA currently marketed product |
| NCT00730990 A Phase I, Healthy Volunteer Positron Emission Tomography Study | Healthy | P1 | Completed | 10 | RCT, Single-blind | PET Scan with PF-03654746, PET Scan with PF-03654746, PET Scan with PF-03654746 |
| NCT00832650 Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal Transit | Healthy | P1 | Terminated | 60 | RCT, Double-blind | fesoterodine fumarate, placebo, solifenacin |
| NCT05525910 Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants | Biological Availability, Healthy Participants | P1 | Completed | 15 | RCT, Open-label | Nirmatrelvir/ ritonavir, Nirmatrelvir/ritonavir, Nirmatrelvir/ritonavir, Nirmatrelvir/ ritonavir, Nirmatrelvir/ ritonavir |
| NCT03159117 Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma | Melanoma | P1 | Completed | 7 | Open-label | PF-06688992 |
| NCT00576589 Study Of The Safety And Pharmacokinetics Of CE-326,597 In Patients With Asymptomatic Gallstones | Obesity | P1 | Completed | 41 | RCT, Double-blind | CE-326,597, Placebo |
| NCT03685591 PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors | Breast Neoplasms, Prostate Neoplasms | P1 | Terminated | 49 | Open-label | PF-06952229, Enzalutamide |
| NCT01537497 A Study To Evaluate The Effects Of PF-05175157 In Healthy Volunteers | Diabetes Mellitus, Type 2 | P1 | Completed | 31 | RCT, Double-blind | PF-05175157, PF-05175157, PF-05175157, Placebo |
| NCT05700396 Breast Cancer Survivor Educational Intervention | Breast Cancer, Breast Neoplasms | N/A | Completed | 7 | Open-label | — |
| NCT00579254 Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors | Hypertension and Cardiovascular Risk Factors | Terminated | 112 | — | CADUET (AMLODIPINE 5 mg/ATORVASTATIN 10 mg or 20 mg) | |
| NCT06151418 A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces | Prostatic Neoplasms | Completed | 2,313 | — | Novel hormonal therapy | |
| NCT02958527 Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE) | Depression/Depressed State | Completed | 1,408 | — | venlafaxine | |
| NCT06072196 A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC) | Prostatic Neoplasms | Completed | 3,017 | — | Novel hormonal therapy | |
| NCT00541476 Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Treated With Lyrica | Neuralgia | Completed | 746 | — | — | |
| NCT05546125 a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China | Pulmonary Arterial Hypertension (PAH) | Completed | 100 | — | — | |
| NCT00674687 A Study Of The Efficacy Of Gabapentin In Neuropathic Pain Patients As Measured By Quantitative Sensory Testing | Neuralgia, Neuralgia, Postherpetic | N/A | Completed | 23 | RCT, Double-blind | 2-weeks placebo then gabapentin, 1-week placebo then gabapentin |
| NCT01243138 Africa and Middle East Cardiovascular Epidemiological Study | Obesity, Smoking | Completed | 4,386 | — | — | |
| NCT00878943 Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study | Pulmonary Arterial Hypertension | NO_LONGER_AVAILABLE | — | — | Sildenafil citrate | |
| NCT01280747 Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study | Fibromyalgia, Painful Diabetic Peripheral Neuropathy | Terminated | 42 | — | — | |
| NCT01773993 Special Investigation of Pregabalin for Fibromyalgia (Regulatory Post Marketing Commitment Plan) | Pain Associated With Fibromyalgia | Completed | 534 | — | Pregabalin | |
| NCT01441401 Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan) | Epilepsies, Partial | Completed | 82 | — | gabapentin | |
| NCT01227395 Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients | HIV Infection | Completed | 476 | — | Azithromycin | |
| NCT05034289 Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy | Clinical Trials, Immunotherapy | N/A | Completed | 81 | Open-label | — |
| NCT01582438 An Open Label Access Study For Subjects Who Completed A1481156 | Pulmonary Arterial Hypertension | NO_LONGER_AVAILABLE | — | — | Access program - sildenafil citrate, Viagra, Revatio | |
| NCT00759174 A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION | Optic Neuropathy, Ischemic | Completed | 673 | — | No intervention | |
| NCT01220180 Lyrica (Pregabalin) Korean Post Marketing Surveillance Study | Epilepsy, Neuropathic Pain | Completed | 4,175 | — | pregabalin (Lyrica), pregabalin (Lyrica), pregabalin (Lyrica) | |
| NCT00946114 To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks | Pulmonary Hypertension | Completed | 32 | — | sildenafil, sildenafil | |
| NCT00486252 Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN® | Glaucoma,Open-Angle, Ocular Hypertension | Completed | 996 | — | — | |
| NCT05902494 HER2 and LA/mUC: A Multi-country Chart Review Cohort Study | Urothelial Carcinoma | Completed | 389 | — | — | |
| NCT03342690 Drug Use Investigation of Selara Tablets (an Investigation for Chronic Heart Failure) | Chronic Heart Failure | Completed | 1,165 | — | Eplerenone | |
| NCT00599768 Development and Validation for Taiwan Version ID Pain Questionnaire (ID Pain-T) and DN4 Questionnaire. | Neuralgia, Nerve Pain | Completed | 325 | — | — | |
| NCT01801982 A Non-Interventional Follow Up Study For Subjects Who Received Sildenafil for Persistent Pulmonary Hypertension of the Newborn (PPHN) | Pulmonary Hypertension, Persistent, of the Newborn | Completed | 1 | — | — | |
| NCT05114902 PCV13 Impact on Pneumococcal Nasopharyngeal Carriage Study | Community-acquired Pneumonia | Unknown | 451 | — | — | |
| NCT01256593 Safety And Efficacy Of Lyrica (Regulatory Post Marketing Commitment Plan) | Neuralgia | Completed | 3,827 | — | Pregabalin (Lyrica) capsule | |
| NCT02922179 Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics | Diabetes | Completed | 103,951 | — | Long- and intermediate- acting insulins | |
| NCT03680365 Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families | Duchenne Muscular Dystrophy, Burden, Dependency | Completed | 60 | — | — | |
| NCT02944344 Four Conversations RCT | Breast Cancer | N/A | Completed | 357 | RCT, Open-label | — |
| NCT02273908 PROs in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin | Low-Back Pain | Completed | 331 | — | — | |
| NCT01206361 Real World Data Study Assessing The Persistency Of Xalacom And The Other Fixed Dose Combination Products, Duotrav And Ganfort, In The United Kingdom | Glaucoma, Ocular Hypertension | Completed | 2,015 | — | XALACOM, Duotrav, Ganfort | |
| NCT00892008 A Post Marketing Surveillance Study On Pregabalin (Lyrica) On Efficacy, Safety And Tolerability Of Pregabalin | Neuropathic Pain | Completed | 2,278 | — | Pregabalin | |
| NCT00801437 Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy. | Glaucoma, Open-angle | Completed | 457 | — | Xalacom | |
| NCT00584519 Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight | Schizophrenia | Completed | 430 | — | — | |
| NCT01279850 Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan) | Neuropathic Pain | Completed | 891 | — | Pregabalin (Lyrica) capsule | |
| NCT00822471 Feasibility and Impact of "ABCs of Diabetes" Self-Management Education Program at an Urban Public Library | Diabetes, Cardiovascular Disease | N/A | Completed | 360 | Open-label | — |
| NCT02922192 Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis | Rheumatoid Arthritis, Inflammatory Bowel Disease | Completed | 90,360 | — | TNF-α antagonists, non-TNFs, DMARD non-biologics | |
| NCT01792622 Patient Reported Outcomes in Pulmonary Arterial Hypertension | Pulmonary Arterial Hypertension | Withdrawn | — | — | — | |
| NCT02868359 PROs in Chronic Cervical Pain Patients With Accompanying Upper Limb Radiating Pain Treated With Pregabalin | Cervical Pain, Neuropathic Pain | Completed | 369 | — | — | |
| NCT01078285 Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor | Medication Non-Adherence | Completed | 500 | — | — | |
| NCT00195338 Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg | Rheumatoid Arthritis | Completed | 25 | — | etanercept | |
| NCT00828945 Compliance With Treatment For Patients With Hyperlipidemia | Hyperlipidemia | Completed | 259 | — | — | |
| NCT01168323 Spaced Education to Optimize Prostate Cancer Screening | Prostate Cancer | N/A | Completed | 95 | RCT, Open-label | — |
| NCT00922987 Clinical Study With Lyrica In Patients Suffering From Epilepsy | Neuralgia, Epilepsy | Completed | 286 | — | Lyrica (pregabalin) | |
| NCT00334750 Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada | Glaucoma, Open-Angle, Ocular Hypertension | Completed | 410 | — | — | |
| NCT02669771 Long-Term Specified Drug Use-Results Survey for Xtandi Capsule | Castration-resistant Prostate Cancer | Completed | 1,018 | — | enzalutamide | |
| NCT06585189 CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS4] | Metastatic Non Small Cell Lung Cancer | Completed | 304 | — | Pembrolizumab, Pemetrexed, Cisplatin, Carboplatin | |
| NCT01191008 Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension | Glaucoma, Ocular Hypertension | Completed | 661 | — | Latanoprost-timolol maleate fixed combination ophthalmic solution | |
| NCT01236261 Prospective Population Study on Candidemia in Spain | Fungemia | Completed | 730 | — | — | |
| NCT00866983 Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil | Pulmonary Arterial Hypertension | NO_LONGER_AVAILABLE | — | — | sildenafil (Revatio) 20 mg TID | |
| NCT00978341 Study to Determine if a Reduction in Pain Can be Measured in Spinal Cord Injured Patients Using a New Study Design | Spinal Cord Injuries | N/A | Terminated | 15 | RCT, Double-blind | Pregabalin, Placebo for pregabalin |
| NCT00270712 A Study of Factors That Affect Long-Term Kidney Transplant Function | Kidney Transplant | Completed | 3,175 | — | — | |
| NCT04504201 Patient-centered Communication About Healthy Weight in Early Breast Cancer | Breast Cancer | Completed | 39 | — | — | |
| NCT01607593 A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients | Posttraumatic Stress Disorder | Completed | 123 | — | sertraline (Zoloft) | |
| NCT01897740 Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil | Pulmonary Arterial Hypertension | NO_LONGER_AVAILABLE | — | — | sildenafil | |
| NCT00709787 Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' Management | Hypertension | Completed | 899 | — | — | |
| NCT00605813 Special Investigation Of Long Term Use Of Sertraline. | Depression, Panic Disorder | Completed | 542 | — | Sertraline hydrochloride | |
| NCT04836221 Comorbidities And Reducing inEquitieS | Cancer, Breast, Diabetes Mellitus | N/A | Completed | 63 | Open-label | — |
| NCT04175262 Clinical Outcomes For Patients With Metastatic Renal Cell Carcinoma (mRCC) Who Received Sunitinib After 1st Line Immune-oncology (IO) Treatments | Metastatic Renal Cell Carcinoma (mRCC) | Completed | 102 | — | sunitinib | |
| NCT00666198 Special Investigation For Long-Term Use Of Sildenafil (Regulatory Post Marketing Commitment Plan) | Pulmonary Hypertension | Completed | 3,337 | — | SILDENAFIL | |
| NCT02380274 Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC) | Prostate Cancer, Castration-resistant Prostate Cancer | Completed | 1,030 | — | — | |
| NCT00579670 Treatment of Schizophrenic Patients With Ziprasidone | Schizophrenia | Completed | 450 | — | Ziprasidone | |
| NCT01053429 A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule | Bipolar Disorder, Schizophrenia | Completed | 3,391 | — | ziprasidone | |
| NCT00768573 Taste Test of a New Formulation of Sildenafil (Revatio) | None Volunteer | Completed | 4 | — | sildenafil | |
| NCT02530944 Web-based Genetic Research on Lupus | Systemic Lupus Erythematosus | Completed | 5,000 | — | — | |
| NCT04076787 Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib | Metastatic Renal Cell Carcinoma | Completed | 1,769 | — | Sunitinib | |
| NCT01150903 Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor | Erectile Dysfunction, Cardiovascular Diseases | Completed | 98,832 | — | — | |
| NCT00567268 Drug Use Investigation Of Gabapentin | Epilepsies, Partial | Completed | 1,273 | — | Gabapentin | |
| NCT02870296 Anticoagulation Medical Home | Venous Thromboembolism, Patient-Centered Care | N/A | Completed | 162 | RCT, Open-label | — |
| NCT05438888 Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data | Non-valvular Atrial Fibrillation | Completed | 77,814 | — | Warfarin, Apixaban | |
| NCT02322580 An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients | Psoriasis | Completed | 56 | — | etanercept | |
| NCT04609319 Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among Asian Patients - A Multi Center Chart Review | Lung Cancer | Completed | 307 | — | Dacomitinib | |
| NCT02454530 Use of Biosimilar Nivestim® to Prevent Chemo-induced Neutropenia. Real Life Study | Chemotherapy-Induced Neutropenia | Terminated | 1,160 | — | Nivestim® | |
| NCT04435769 Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment | Atrial Fibrillation | Completed | 109 | — | — | |
| NCT03276754 Immunization To Prevent Acute COPD Exacerbations | Pneumococcal Infections, COPD | Terminated | 530 | — | — | |
| NCT00293722 Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists | Arthritis, Psoriatic, Psoriasis | Completed | 1,308 | — | Etanercept | |
| NCT01329783 EuroSIDA As An External Comparator To MOTIVATE Trials | HIV, AIDS | Completed | 1,181 | — | — | |
| NCT00338741 Rebif® Pregnancy Registry | Multiple Sclerosis | Completed | 36 | — | — | |
| NCT00002305 A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis | Meningitis, Cryptococcal, HIV Infections | N/A | Completed | — | — | Flucytosine, Fluconazole, Amphotericin B |
| NCT00258869 Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests | Sepsis, Septicemia | Unknown | 1,200 | — | — | |
| NCT04176354 Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy | Metastatic Breast Cancer | Completed | 813 | — | Palbociclib + an aromatase inhibitor, Palbociclib + Letrozole, Letrozole | |
| NCT02789137 Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment | Metastatic Renal Cell Carcinoma | Completed | 111 | — | — | |
| NCT01648751 Vaginal Estrogen and Pelvic Floor Physical Therapy in Women With Symptomatic Mild Prolapse | Pelvic Organ Prolapse | N/A | Terminated | 21 | RCT, Double-blind | Vaginal estrogen, Placebo |
| NCT01747369 Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013 | Pneumonia, Bacterial, Pneumonia, Viral | Unknown | 2,000 | — | — | |
| NCT05452798 A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib in Denmark | Breast Cancer | Completed | 1,054 | — | — | |
| NCT00770887 Self Administration of Subcutaneous Depot Medroxyprogesterone Acetate | Fertility | Completed | 50 | — | — | |
| NCT00929721 A Global Active Surveillance for Community Acquired Pneumonia | Community Acquired Pneumonia | N/A | Completed | 5,172 | Open-label | — |
| NCT00002306 A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B | Meningitis, Cryptococcal, HIV Infections | N/A | Completed | — | — | Fluconazole |
| NCT00329069 The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia | Coronary Artery Disease, Hypercholesterolemia | N/A | Completed | 50 | RCT, Double-blind | atorvastatin (drug) |
| NCT00697112 Study Evaluating The Use Of Sirolimus In Recipients Of Kidney Allografts From Expanded Criteria Donors (ECD) | Renal Transplantation | Completed | 53 | — | Sirolimus | |
| NCT00488475 Observational Trial With Enbrel | Rheumatoid Arthritis | Completed | 4,945 | — | etanercept | |
| NCT02539368 Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease | Inflammatory Bowel Diseases, Ulcerative Colitis | Completed | 2,565 | — | CT-P13, Remicade | |
| NCT00754260 Caffeine Reduction and Overactive Bladder Symptoms | Overactive Bladder | N/A | Terminated | 42 | RCT, Single-blind | — |
| NCT00845273 Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration | Macular Degeneration | Completed | 3,538 | — | Pegaptanib sodium | |
| NCT01981473 Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab | Rheumatoid Arthritis | Completed | 605 | — | — | |
| NCT04744454 Post Marketing Surveillance (PMS) Study of Cresemba in Korea. | Aspergillosis, Mucormycosis | Completed | 94 | — | Isauvuconazole group | |
| NCT04428424 Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients | Arthritis, Rheumatoid | Completed | 1,493 | — | Enbrel | |
| NCT01790828 Post Marketing Surveillance To Observe Safety And Efficacy Of Xyntha® In Subjects With Hemophilia A | Hemophilia A | Completed | 42 | — | Xyntha : coagulation factor IIIV (recombinant) | |
| NCT01414257 Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan) | Arthritis, Rheumatoid | Completed | 2,860 | — | Methotrexate (MTX) | |
| NCT06634836 Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & B | Hemophilia A, Hemophilia B | Withdrawn | — | — | — | |
| NCT00943735 This Is An Open-Label Study To Evaluate Fesoterodine Plus "Your Way" Patient Support Plan In Patients With Symptoms Of Overactive Bladder | Overactive Bladder | Completed | 774 | — | Fesoterodine | |
| NCT02432430 Comparison of Immunization Quality Improvement Dissemination Study | Immunization, DTaP Vaccine | N/A | Completed | 2,186 | RCT, Single-blind | — |
| NCT03375242 Safety and Efficacy of Xalkori ROS1 | Non-small Cell Lung Cancer | Completed | 97 | — | crizotinib | |
| NCT00465894 Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms | Overactive Bladder | N/A | Completed | 58 | RCT, Open-label | Extended Release Tolterodine LA, Intra Vaginal Estradiol Cream |
| NCT05372575 A COHORT STUDY TO EVALUATE IMMUNOGENICITY FOR CHINESE CHILDREN AT THE TIME OF CLINICAL PNEUMONIA DIAGNOSIS | Immunogenicity, Vaccine | N/A | Completed | 300 | Open-label | PCV13 PAC study |
| NCT00002294 A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS | Meningitis, Cryptococcal, HIV Infections | N/A | Completed | — | Double-blind | Fluconazole |
| NCT02531061 Impact of the Persistence of Inflammation at Doppler Ultrasound Level on the Structural Evolution of Erosion in Rheumatoid Arthritis Treated With Biotherapy | Rheumatoid Arthritis | N/A | Completed | 35 | Open-label | — |
| NCT05269069 Impact of Rheumatoid Arthritis on Body Composition, Bone Marrow Adiposity and Bone Mineral Density: a Case-control Study | Rheumatoid Arthritis | Terminated | 52 | — | — | |
| NCT00505297 A Longitudinal Study of Osteoarthritis (OA) Disease Progression Measured by MRI, dGEMRIC, and Radiography | Osteoarthritis | Completed | 18 | — | — | |
| NCT00576576 Evaluation of Atorvastatin on Atherosclerosis Composition | Atherosclerosis | N/A | Completed | 27 | Open-label | Atorvastatin |
| NCT04613375 PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older | Community Acquired Pneumonia (CAP) | Completed | 1,821 | — | — | |
| NCT00564174 Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT | Recurrent Pregnancy Loss, Antiphospholipid Antibody Syndrome | N/A | Terminated | 88 | RCT, Open-label | Low molecular weight heparin and low dose aspirin, Low dose aspirin |
| NCT00002090 An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS) | Mycobacterium Avium-Intracellulare Infection, HIV Infections | N/A | Completed | — | — | Azithromycin |
| NCT07235397 Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset | Respiratory Syncytial Virus Infections | Not Yet Recruiting | 1 | — | ABRYSVO | |
| NCT05471505 Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding | Non-valvular Atrial Fibrillation | Completed | 120,722 | — | — | |
| NCT00288366 Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome | Schizophrenia, Schizoaffective Disorder | N/A | Completed | 49 | RCT, Open-label | ziprasidone vs. aripiprazole, aripiprazole vs. ziprasidone |
| NCT00823966 Safety And Efficacy Of Rescriptor In Patients For Human Immunodeficiency Virus (HIV) Patients | HIV-1 Infection | Completed | 3 | — | Rescriptor | |
| NCT01073644 Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients | Metastatic Renal Cell Carcinoma | Terminated | 3 | — | Sunitinib malate | |
| NCT02461602 Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients | Atrial Fibrillation | Completed | 251 | — | — | |
| NCT03220230 Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients. | Lung Neoplasms | Completed | 4,240 | — | — | |
| NCT00749320 Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC) | Renal Cell Carcinoma | N/A | Completed | 32 | Open-label | — |
| NCT00167973 Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use | Hemophilia B | Completed | 218 | — | — | |
| NCT04647110 Real-world Therapy of ALK-positive NSCLC in Sweden: the Sequencing of ALK Tyrosine Kinase Inhibitor Drugs and Their Therapeutic Outcomes Based on Data From National Registers. | ALK-positive NSCLC | Completed | 549 | — | crizotinib, alectinib, brigatinib, ceritinib, lorlatinib | |
| NCT01260311 Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder | Over Active Bladder | Completed | 508 | — | Fesoterodine | |
| NCT01363271 Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients | Complicated Skin and Structure Infection, Nosocomial Pneumonia | Completed | 7,260 | — | Linezolid, Vancomycin, Linezolid, Vancomycin | |
| NCT06688838 Effective Treatment of Jak1/3 Inhibitor in Blau Syndrome | Blau Syndrome | By Invite | 24 | — | Tofacitinib | |
| NCT02264665 OPALINE : A Study Of Morbidity And Mortality At 2 Years | Pancreatic Neuroendocrine Tumor, Well Differentiated and Progressive | Completed | 144 | — | sunitinib, everolimus, chemotherapies recommended in france | |
| NCT05568407 A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer | Bladder Cancer | Terminated | 19 | — | Avelumab | |
| NCT03105271 Acute Kidney Injury in Patients With Sickle Cell Disease | Sickle Cell Disease, Kidney Injury | Completed | 60 | — | — | |
| NCT03096509 Participatory Action Research to Evaluate the Delivery of the MISSION ABC Service Model and Assess Health Service and Clinical Outcomes | COPD, Asthma | Completed | 342 | — | — | |
| NCT01396434 Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos | Pneumococcal Disease | Completed | 3,006 | — | Prevenar 13 | |
| NCT00444899 Clinical and Economic Benefits of Cardiovascular Risk Management by a Dietician in Type 2 Diabetes Patients | Type 1 Diabetes, Type 2 Diabetes | N/A | Completed | 101 | RCT, Open-label | — |
| NCT07527832 An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan. | Colorectal Cancer | Completed | 1,000 | — | Bevacizumab-Pfizer Biosimilar, Avastin | |
| NCT03812835 A Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment | Thrombosis, Deep Vein, Pulmonary Embolism | Withdrawn | — | — | — | |
| NCT00396474 Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height | Infant, Small for Gestational Age | Withdrawn | — | — | — | |
| NCT05597085 A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment | Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia | Completed | 32 | — | Inotuzumab Ozogamicin | |
| NCT00884468 Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis | Psoriatic Arthritis | Completed | 384 | — | — | |
| NCT01326468 Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer | Head and Neck Cancer | N/A | Withdrawn | — | Open-label | Temsirolimus, Cetuximab, Cisplatin |
| NCT00378989 The Effectiveness of Health Advice and Occupational Health Intervention on Work Ability | Signs and Symptoms | N/A | Completed | 418 | RCT, Single-blind | — |
| NCT01707576 Screening of Adolescent Mental Suffering | Depression, Adolescent | N/A | Completed | 346 | Open-label | — |
| NCT00902785 A Study Of Early Markers Of Choroidal Neovascularization | Choroidal Neovascularization (CNV), Age-related Macular Degeneration (AMD) | Terminated | 100 | — | — | |
| NCT00438555 Randomized, Controlled, Open, Comparative Intervention Study for Obesity Prevention in Children | Obesity | N/A | Completed | 248 | RCT, Open-label | — |
| NCT02188667 Integrating Patient Reported Outcomes (I-PRO) Study for Multidisciplinary Pain Care | Chronic Noncancer Pain | N/A | Completed | 21 | RCT, Open-label | — |
| NCT02192164 Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis | Plaque Psoriasis | Completed | 126 | — | — | |
| NCT00163618 Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children | Encephalitis, Tick-borne | Completed | — | — | Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl | |
| NCT01617018 Assessing the Long Term Effectiveness and Safety of Biotherapies in the Treatment of Cutaneous Psoriasis | Psoriasis | Completed | 4,613 | — | — |